DEF 14A
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(RULE 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No.     )

Filed by the Registrant  x                             Filed by a Party other than the Registrant  ¨

Check the appropriate box:

 

¨    Preliminary Proxy Statement
¨    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
x    Definitive Proxy Statement
¨    Definitive Additional Materials
¨    Soliciting Material Pursuant to §240.14a-12

CENTENE CORPORATION

(Name of Registrant as Specified In Its Charter)

Payment of Filing Fee (Check the appropriate box):

x   No fee required.
¨   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

 

   

 

  (2)  

Aggregate number of securities to which transaction applies:

 

 

   

 

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

   

 

  (4)  

Proposed maximum aggregate value of transaction:

 

 

   

 

  (5)   Total fee paid:
   
   

 

¨   Fee paid previously with preliminary materials.
¨   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

 

   

 

  (2)  

Form, Schedule or Registration Statement No.:

 

 

   

 

  (3)  

Filing Party:

 

 

   

 

  (4)  

Date Filed:

 

 

   

 

 

 

 


Table of Contents

 

 

Notice of Annual Meeting

of Stockholders and

2016 Proxy Statement

 

 

March 11, 2016

 

LOGO


Table of Contents

 

LOGO

CENTENE CORPORATION

Centene Plaza

7700 Forsyth Boulevard

St. Louis, Missouri 63105

March 11, 2016

Dear Fellow Stockholders:

Our 2016 Annual Meeting of Stockholders will be held at Centene Plaza, 7700 Forsyth Boulevard, St. Louis, Missouri, at 10:00 A.M., central daylight savings time, on Tuesday, April 26, 2016. Annual meetings play an important role in maintaining communications and understanding among our management, Board of Directors and stockholders, and I hope that you will be able to join us.

We are pleased to continue taking advantage of the Securities and Exchange Commission rule allowing companies to furnish proxy materials to their stockholders over the Internet. We believe that this e-proxy process expedites stockholders’ receipt of proxy materials, lowers the costs and reduces the environmental impact of our annual meeting. On or about March 14, 2016, we will begin mailing to our stockholders a proxy notice containing instructions on how to access our Proxy Statement, Annual Review and Annual Report on Form 10-K, and vote on-line. Information concerning the matters to be considered and voted upon at the Annual Meeting is set forth in the Notice of 2016 Annual Meeting of Stockholders and Proxy Statement. The Proxy Statement contains instructions on how you can receive a paper copy of the Proxy Statement, Annual Review and Annual Report on Form 10-K, if you only received a proxy notice by mail.

If you are a stockholder of record you may vote:

 

  ¡   via internet;

 

  ¡   by telephone;

 

  ¡   by mail; or,

 

  ¡   in person at the meeting.

To vote by internet or telephone, please follow the instructions on the proxy notice. To vote by mail, request a set of proxy materials as instructed on the proxy notice. You may attend the meeting and vote in person even if you have previously voted.

If your shares are held in the name of a bank, broker or other holder of record, you will receive instructions from the holder of record that you must follow in order for your shares to be voted.

Sincerely,

 

LOGO

Michael F. Neidorff

Chairman, President and

Chief Executive Officer

 

 

THE ABILITY TO HAVE YOUR VOTE COUNTED AT THE MEETING IS AN IMPORTANT

STOCKHOLDER RIGHT, AND I HOPE YOU WILL CAST YOUR VOTE IN PERSON

OR BY PROXY REGARDLESS OF THE NUMBER OF SHARES YOU HOLD.

 

 


Table of Contents

CENTENE CORPORATION

CENTENE PLAZA

7700 FORSYTH BOULEVARD

ST. LOUIS, MISSOURI 63105

NOTICE OF 2016 ANNUAL MEETING OF STOCKHOLDERS

 

Time and Date    10:00 A.M., central daylight savings time, on Tuesday, April 26, 2016
Place   

Centene Plaza

7700 Forsyth Boulevard

St. Louis, Missouri 63105

Centene Auditorium

Items of Business    At the meeting, we will ask you and our other stockholders to consider and act upon the following matters:
   (1) to elect three Class III Directors to three-year terms;
   (2) advisory resolution to approve executive compensation;
   (3) to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016; and
   (4) to transact any other business properly presented at the meeting.
Record Date    You may vote if you were a stockholder of record at the close of business on February 26, 2016.
Proxy Voting    It is important that your shares be represented and voted at the meeting. Whether or not you plan to attend the meeting, please vote by internet, telephone or mail. You may revoke your proxy at any time before its exercise at the meeting. Please reference the proxy notice for additional information.
Stockholder List    A list of stockholders entitled to vote will be available at the meeting. In addition, you may contact our Secretary, Keith H. Williamson, at our address as set forth above, to make arrangements to review a copy of the stockholder list at our offices located at 7700 Forsyth Boulevard, St. Louis, Missouri, before the meeting, between the hours of 8:00 A.M. and 5:00 P.M., central daylight savings time, on any business day from April 12, 2016, up to one hour prior to the time of the meeting.
Attending the Annual Meeting    If you would like to attend the meeting, please bring evidence to the meeting that you own common stock, such as a stock certificate, or, if your shares are held by a broker, bank or other nominee, please bring a recent brokerage statement or a letter from the nominee confirming your beneficial ownership of such shares. You must also bring a form of personal identification.

 

By order of the Board of Directors,
  LOGO
  Keith H. Williamson
  Secretary

St. Louis, Missouri

March 11, 2016


Table of Contents

Table of Contents

Information About the Meeting      1   
Proposal One: Election of Directors      3   

Nominees and Continuing Directors

     3   

Corporate Governance and Risk Management

     7   

Compensation Committee Interlocks and Insider Participation

     8   

Related Party Transactions

     8   

Director Independence

     9   

Board of Directors Committees

     9   

Director Candidates

     13   

Communicating with Independent Directors

     14   

Director Compensation

     15   
Proposal Two: Advisory Resolution to Approve Executive Compensation      17   
Proposal Three: Ratification of Appointment of Independent Registered Public Accounting Firm      18   
Audit Committee Report      20   
Information About Executive Compensation      22   

Compensation Committee Report

     22   

Compensation Discussion and Analysis

     23   

Equity Compensation Plan Information

     40   

Summary Compensation Table

     41   

Grants of Plan-Based Awards Table

     42   

Outstanding Equity Awards at Fiscal Year-End Table

     43   

Option Exercises and Stock Vested Table

     44   

Nonqualified Deferred Compensation Table

     45   

Potential Payments Upon Termination or Change in Control

     46   
Other Matters      49   

Information About Stock Ownership

     49   

Section 16(a) Beneficial Ownership Reporting Compliance

     51   

Submission of Future Stockholder Proposals

     51   

Householding

     52   


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

 

 

Information About the Meeting

 

 

We have sent you a notice of this proxy statement because our Board of Directors is soliciting your proxy to vote at our 2016 Annual Meeting of Stockholders or any adjournment or postponement of the meeting.

When and where is the annual meeting?

  When: Tuesday, April 26, 2016 at 10:00 a.m., central daylight savings time

 

  Where: Centene Plaza, 7700 Forsyth Boulevard, St. Louis, Missouri.

 

  ¡   THIS PROXY STATEMENT summarizes information about the proposals to be considered at the meeting and other information you may find useful in determining how to vote.

 

  ¡   THE PROXY CARD is the means by which you actually authorize another person to vote your shares in accordance with the instructions.

Our Directors, Officers and employees may solicit proxies in person or by telephone, mail, electronic mail or facsimile. We will pay the expenses of soliciting proxies, although we will not pay additional compensation to these individuals for soliciting proxies. We will request banks, brokers and other nominees holding shares for a beneficial owner to forward copies of the proxy materials to those beneficial owners and to request instructions for voting those shares. We will reimburse these banks, brokers and other nominees for their related reasonable expenses. The Company has retained Morrow & Co., LLC to assist in the solicitation of proxies at an estimated cost of $12,500, plus expenses.

We are making this proxy statement, our 2015 Annual Review to Stockholders and our Annual Report on Form 10-K for the fiscal year ended December 31, 2015 available to stockholders for the first time on or about March 14, 2016.

Who is entitled to vote at the meeting?

Holders of record of our common stock at the close of business on February 26, 2016 are entitled to one vote per share on each matter properly brought before the meeting. The proxy notice states the number of shares you are entitled to vote.

You may vote your shares at the meeting in person or by proxy:

 

  ¡   TO VOTE IN PERSON, you must attend the meeting, and then complete and submit the ballot provided at the meeting. If your shares are held in the name of a bank, broker or other nominee holder, you will receive instructions from the holder of record explaining how your shares may be voted. Please note that, in such an event, you must obtain a proxy, executed in your favor, from the holder of record to be able to vote at the meeting.

 

  ¡   TO VOTE BY PROXY, you must follow the instructions on the proxy notice and then vote by means of the internet, telephone or, if you received your proxy materials by mail, mailing the proxy card in the enclosed postage-paid envelope. Your proxy will be valid only if you vote before the meeting. By voting, you will direct the designated persons to vote your shares at the meeting in the manner you specify. If, after requesting paper materials, you complete the proxy card with the exception of the voting instructions, then the designated persons will vote your shares in accordance with the instructions contained therein, and if no choice is specified, such proxies will be voted in favor of the matters set forth in the accompanying Notice of 2016 Annual Meeting of Stockholders. If any other business properly comes before the meeting, the designated persons will have the discretion to vote your shares as they deem appropriate.

 

Centene Corporation    1


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

INFORMATION ABOUT THE MEETING

 

Even if you vote by means of the internet, telephone, or complete and return a proxy card, you may revoke it at any time before it is exercised by taking one of the following actions:

 

  ¡   send written notice to Keith H. Williamson, our Secretary, at our address as set forth in the accompanying Notice of 2016 Annual Meeting of Stockholders;

 

  ¡   submit a new vote by means of the mail, internet or telephone; or

 

  ¡   attend the meeting, notify our Secretary that you are present, and then vote by ballot.

What do I need to do if I plan to attend the meeting in person?

If you would like to attend the meeting, please bring evidence to the meeting that you own common stock, such as a stock certificate, or, if your shares are held by a broker, bank or other nominee, please bring a recent brokerage statement or a letter from the nominee confirming your beneficial ownership of such shares. You must also bring a form of personal identification.

At the close of business on February 26, 2016, 121,667,250 shares of our common stock were outstanding, net of treasury shares. Our By-Laws require that a majority of the shares of our common stock issued and outstanding on that date be represented, in person or by proxy, at the meeting in order to constitute the quorum we need to transact business. We will count abstentions and broker non-votes in determining whether a quorum exists. A broker non-vote occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power for that particular item and has not received instructions from the beneficial owner.

In the election of directors, the three nominees receiving the greatest number of votes cast “FOR” shall be elected as directors, unless otherwise determined in accordance with our majority voting policy. This policy states that in an uncontested election, any Director nominee who receives a greater number of votes “withheld” for his or her election than “FOR” votes, the Director nominee must tender his or her resignation promptly following certification of the stockholder vote. The Nominating and Governance Committee is required to make a recommendation to the Board of Directors with respect to any such tendered resignation. The Board of Directors will act on the tendered resignation within 90 days from the certification of the vote and will publicly disclose its decision, including an explanation of its decision. Broker non-votes will have no effect on the voting outcome with respect to the election of directors.

The affirmative vote of the holders of a majority of the votes cast at the meeting is necessary to ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016 and to approve on an advisory non-binding basis, the Company’s executive compensation. Abstentions and broker non-votes with respect to each of these proposals will not be considered as votes cast with respect to the matter and thus will have no effect on the vote.

Our Board of Directors is not aware of any matters that are expected to come before the meeting other than those referred to in this proxy statement. If any other matter should properly come before the meeting, the persons appointed as proxies by the Board of Directors intend to vote the proxies in accordance with their best judgment.

The chairperson of the meeting may refuse to allow the transaction of any business not presented beforehand, or to acknowledge the nomination of any person not made, in compliance with the below procedures.

 

2    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

 

Proposal One: Election Of Directors

 

 

Nominees and Continuing Directors

 

 

Our Certificate of Incorporation provides that the Board is to be divided into three classes serving for staggered three-year terms. Under our By-Laws, our Board of Directors has the authority to fix the number of Directors, provided that the Board must have between five and eleven members. The first proposal on the agenda for the meeting is the election of three nominees to serve as Class III Directors for three-year terms beginning at the meeting and ending at our 2019 Annual Meetings of Stockholders.

In February 2016, Ms. Joseph discussed with the Board of Directors her anticipated external executive officer commitments including scheduling conflicts with the 2016 Board of Directors meeting schedule requirements. As a result, the Board concluded that Ms. Joseph would not be able to serve the board in 2016 if re-elected and did not nominate her for re-election. If Ms. Joseph’s scheduling conflicts are resolved in the future, the Nominating and Governance Committee will consider her nomination for re-election onto the Board.

Pursuant to the terms of the July 2015 definitive merger agreement to acquire the issued and outstanding shares of Health Net, Inc., we are obligated following closing to appoint to our Board of Directors, a current member of the Health Net board of directors. The Board of Directors anticipates that this new director would be appointed as a Class I director, standing for election at the 2017 Annual Meeting of Stockholders. Therefore, as a practice of good corporate governance, the Board of Directors is rebalancing the three classes of directors by nominating John R. Roberts, a current Class I director, for election as a Class III director at the 2016 Annual Meeting of Stockholders.

No Director, including any Director standing for election, or any associate of a Director, is a party adverse to us or any of our subsidiaries in any material proceeding or has any material interest adverse to us or any of our subsidiaries. No Director, including any Director standing for election, is related by blood, marriage or adoption to any other Director or any Executive Officer.

The Board has nominated Orlando Ayala, John R. Roberts and Tommy G. Thompson for re-election to the Board. We expect that Mr. Ayala, Mr. Roberts and Mr. Thompson will be able to serve if elected. If any of them are not able to serve, proxies may be voted for a substitute nominee or nominees. The Board believes the election of these three nominees is in our best interest and the best interest of our stockholders and recommends a vote “FOR” the election of the three nominees.

 

Centene Corporation    3


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

 

 

Class III Directors Continuing in Office—Standing for Election for a Term Expiring in 2019

 

 

 

Orlando Ayala

 

Principal Occupation:   Chairman and Corporate Vice President of Emerging Businesses for Microsoft                                              Corporation

First Became Director: September 2011

Age: 59

 

Mr. Ayala serves as Chairman and Corporate Vice President of Emerging Businesses for Microsoft Corporation. Mr. Ayala joined Microsoft in 1991 as Senior Director of the Latin America region. For more than 30 years, Mr. Ayala has held increasingly senior leadership roles in the technology sector.

Qualifications: Mr. Ayala’s range of experience includes, in particular, technology and organizational development expertise.

 

 

John R. Roberts

 

Principal Occupation:  Retired Regional Managing Partner, Arthur Andersen LLP

First Became Director: March 2004

Age: 74

 

Mr. Roberts has been a Director since March 2004. Mr. Roberts is a retired Managing Partner, Mid-South Region, Arthur Andersen LLP. He also serves as a Director and Chairman of the audit committee of Energizer Holdings, Inc. Mr. Roberts previously served as a Director for Regions Financial Corporation.

Qualifications: Mr. Roberts’ range of experience includes, in particular, organizational development expertise as well as experience in financial service industries and public accounting.

 

 

 

 

Tommy G. Thompson

 

Principal Occupation:  Chairman and Chief Executive Officer of Thompson Holdings; Retired Partner in the law                                             firm of Akin Gump Strauss Hauer & Feld LLP; Former Governor of the State of                                              Wisconsin; Former Health and Human Services Secretary

First Became Director: April 2005

Age: 74

 

Mr. Thompson has served as Chairman and Chief Executive Officer of Thompson Holdings since 2012. Mr. Thompson served as Partner in the law firm of Akin Gump Strauss Hauer & Feld LLP in Washington, D.C. from 2005 to 2012 and as President of Logistics Health, Inc. from 2005 to 2011. From 2001 to 2005, Mr. Thompson served as secretary of U.S. Department of Health & Human Services. From 1987 to 2001, Mr. Thompson served as Governor of the State of Wisconsin. He also serves as a Director for C.R. Bard, Inc., Cytori Therapeutics, Inc., TherapeuticsMD Inc., Physicians Realty Trust and United Therapeutics Corp.

In 2015, Mr. Thompson expressed his intention to the Company to reduce his participation to a total of five boards, including Centene. In February 2016, Mr. Thompson notified Cytori Therapeutics, Inc. that he would be unable to stand for re-election to Director in April 2016, bringing Mr. Thompson’s board membership within our corporate governance guideline. Mr. Thompson previously served as a Director for AGA Medical Corp., Cancer Genetics, CareView Communications and CNS Response.

Qualifications: Mr. Thompson’s range of experience includes, in particular, experience as a Chief Executive Officer, political and regulatory relationships and healthcare expertise.

 

4    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

 

  

 

Class III Director Not Continuing in Office—Term Expiring in 2016

 

 

 

Pamela A. Joseph

 

Principal Occupation:   Retired Vice Chairman of U.S. Bancorp and Chairman and Chief Executive Officer of                                              Elavon, Inc.; Effective May 1, 2016, President and Chief Operating Officer of TSYS

First Became Director: September 2007

Age: 57

 

Ms. Joseph served as Vice Chairman of U.S. Bancorp (banking and financial services industries) and Chairman and Chief Executive Officer of Elavon, Inc. (a subsidiary of U.S. Bancorp) from 2004 until her retirement in 2015. She serves as a Director for Paychex, Inc. and TransUnion.

Qualifications: Ms. Joseph’s range of experience includes, in particular, experience as a Chief Executive Officer, as well as technology and service industry expertise.

 

 

Class I Directors—Term Expiring in 2017

 

 

 

Michael F. Neidorff

 

Principal Occupation:  Chairman, President and Chief Executive Officer of Centene Corporation

First Became Director: May 1996

Age: 73

 

Mr. Neidorff has served as our Chairman, President and Chief Executive Officer since May 2004. From May 1996 to May 2004, Mr. Neidorff served as President, Chief Executive Officer and as a member of our Board of Directors. Mr. Neidorff previously served as a director of Caleres, Inc.

Qualifications: Mr. Neidorff’s range of experience includes, in particular, experience as a Chief Executive Officer, as well as healthcare, investment banking and organizational development expertise.

 

 

 

Richard A. Gephardt

 

Principal Occupation:  Chief Executive Officer and President of Gephardt Group, LLC;

                                            Former Majority Leader of the U.S. House of Representatives

First Became Director: December 2006

Age: 75

 

Mr. Gephardt has served as Chief Executive Officer and President of Gephardt Group, LLC (consulting business) since 2005. Mr. Gephardt served as a Member of the U.S. House of Representatives from 1977 to 2005; he was House Majority Leader from 1989 to 1995 and Minority Leader from 1995 to 2003. He also serves as a Director for Spirit Aerosystems Holdings, Inc. and CenturyLink, Inc. Mr. Gephardt previously served as a Director for Ford Motor Company and US Steel Corporation.

Qualifications: Mr. Gephardt’s range of experience includes, in particular, political and regulatory relationships as well as investment banking and healthcare expertise.

 

Centene Corporation    5


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

 

 

Class II Director Continuing in Office—Term Expiring in 2018

 

 

 

Robert K. Ditmore

 

Principal Occupation:   Retired Director, President and Chief Operating Officer of United Healthcare Corporation

First Became Director: 1996

Age: 81

 

Mr. Ditmore is a retired Director, President and Chief Operating Officer of United Healthcare Corporation (managed care industry), now known as UnitedHealth Group, Inc.

Qualifications: Mr. Ditmore’s range of experience includes, in particular, Chief Executive Officer roles and extensive healthcare and service industry expertise.

 

 

 

Frederick H. Eppinger

 

Principal Occupation:  Director, President and Chief Executive Officer of The Hanover Insurance Group, Inc.

First Became Director: April 2006

Age: 57

 

Mr. Eppinger has served as a Director, President and Chief Executive Officer of The Hanover Insurance Group, Inc. (insurance and financial services industries) since 2003.

Qualifications: Mr. Eppinger’s range of experience includes, in particular, Chief Executive Officer roles, as well as organizational development and insurance industry expertise.

 

 

 

David L. Steward

 

Principal Occupation:  Founder and Chairman of World Wide Technology, Inc.

First Became Director: May 2003

Age: 64

 

Mr. Steward is the founder of World Wide Technology, Inc. (systems integration industry) and has served as its Chairman since its founding in 1990. In addition, Mr. Steward has served as Chairman of Telcobuy.com (an affiliate of World Wide Technology, Inc.), since 1997. He also served as Director of First Banks, Inc., a registered bank holding company, from 2000 to 2013.

Qualifications: Mr. Steward’s range of experience includes, in particular, Chief Executive Officer roles, political and regulatory relationships, as well as technology expertise.

 

6    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

 

Corporate Governance and Risk Management

 

 

We believe that good corporate governance is important to ensure that we are managed for the long term benefit of our stockholders. We also recognize the connection between good corporate governance and our ability to create and sustain value for our stockholders. Our Ethics and Compliance Program provides methods by which we further enhance operations, safeguard against fraud and abuse and help assure that our values are reflected in everything we do. We have also reviewed and believe we are in compliance with the provisions of the Sarbanes-Oxley Act of 2002, the rules of the SEC, and the listing standards of the New York Stock Exchange (NYSE). Our Board of Directors has adopted Corporate Governance Guidelines addressing, among other things, Director qualifications and responsibilities, duties of key Board committees, Director compensation and management succession. A current copy of the Corporate Governance Guidelines is posted on our website, www.centene.com.

Our Board of Directors has adopted a Business Ethics and Conduct Policy (the Policy) which is applicable to all Directors, Officers and employees of the Company, including the Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer. While no policy can replace the thoughtful behavior of an ethical Director, Officer or employee, we believe the Policy will, among other things, focus our Board and management on areas of ethical risk, provide guidance in recognizing and dealing with ethical issues, provide mechanisms to report unethical conduct and generally help foster a culture of honesty and accountability. Any amendment or waiver of the Policy may only be made by the Board or a committee of the Board. A current copy of the Policy is posted on our website, www.centene.com. Any future amendments or waivers of the Policy will be promptly disclosed on our website.

Our policy concerning pre-approval of related party transactions is incorporated into the provisions of the Policy regarding conflicts of interest. As part of the Policy, our Directors, Officers and employees are responsible for disclosing any transaction or relationship that reasonably could be expected to give rise to a conflict of interest to the Chief Compliance Officer of the Company or the Board of Directors, in the case of an Executive Officer or Director, who shall be responsible for determining whether such transaction or relationship constitutes a conflict of interest.

The Board of Directors oversees the Company’s enterprise-wide risk management processes, with assistance provided by Board committees. Management executes risk management activities, which includes identifying, assessing, and aligning actions necessary to manage risk consistent with the Company’s strategy.

The oversight responsibility of the Board of Directors and its committees is enabled by quarterly risk reporting to the Board from executive management, designed to provide visibility about the identification, assessment and management of critical risks, including strategic, operational, financial, compensation, public policy, compliance, regulatory, investment, information security and other risks. Furthermore, the Board of Directors and its committees are informed of emerging risks that could affect the Company’s risk profile. The Board also evaluates Company performance in relation to tolerance levels established in our risk appetite framework.

 

Centene Corporation    7


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

As noted above, the Board uses its committees to assist in its risk oversight function:

 

  ¡   Our Audit Committee assists in the oversight of our financial and reporting risks, disclosure risk and procedures, business ethics and conduct risks, investment, and risk assessment and management policies. The Company’s Executive Vice President of Internal Audit & Risk Management, who reports to the Audit Committee and Chief Executive Officer, assists the Company in identifying and evaluating risk management controls and methodologies to address risks and provides reports to the Audit Committee quarterly. The Audit Committee meets privately with representatives from the Company’s independent registered public accounting firm and the Company’s Executive Vice President of Internal Audit & Risk Management.

 

  ¡   Our Compensation Committee assists in the oversight of risks associated with our compensation plans and policies. Please see the discussion in the “Compensation Discussion & Analysis,” or “CD&A,” under the heading “Risk Disclosure” for a discussion of elements intended to mitigate excessive risk taking by our employees.

 

  ¡   Our Nominating and Governance Committee assists in the oversight of Board processes and corporate governance-related risk.

 

 

Compensation Committee Interlocks and Insider Participation

 

 

Robert K. Ditmore (Chair), Orlando Ayala, Pamela A. Joseph, David L. Steward and Tommy G. Thompson were members of the Compensation Committee during 2015. During 2015, none of our executive officers served as a Director or member of the Compensation Committee, or other committee serving an equivalent function, of any other entity that has one or more of its executive officers serving as a member of our Board of Directors or Compensation Committee. During 2015, no member of the Compensation Committee had a relationship that must be described under the SEC rules relating to disclosure of related person transactions. None of the current members of our Compensation Committee has ever been an officer or employee of Centene or any of our subsidiaries.

 

 

Related Party Transactions

 

 

None.

 

8    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

 

Director Independence

 

 

Our Board of Directors has affirmatively determined that all Directors except Michael F. Neidorff, our Chairman, President and Chief Executive Officer, as well as all of the members of each of the Board’s committees, are independent as defined under the rules of the NYSE, including, in the case of all members of the Audit Committee, the independence requirements contemplated by Rule 10A-3 under the Exchange Act and in the case of all members of the Compensation Committee, the enhanced independence requirements under the rules of the NYSE. In the course of the Board’s determination regarding the independence of each non-employee Director, it considered any transactions, relationships and arrangements as required by the rules of the NYSE. In particular, with respect to each of the most recent three completed fiscal years, the Board evaluated:

 

  ¡   Mr. Ayala’s position as a Vice President of Microsoft Corporation, from whom the Company licenses certain software, and determined that the payments made pursuant to such licenses from 2013—2015 were under 2% of Microsoft’s annual revenues during the respective years.

 

  ¡   Ms. Joseph’s position as an Executive Officer of U.S. Bancorp, serving as a lender under the Company’s revolving credit facility, and determined that payments to the lender from 2013—2015 were under 2% of the lender’s annual revenues during the respective years.

 

  ¡   Mr. Roberts’ previous position as an independent director of a bank serving as a lender under the Company’s revolving credit facility and determined payments to the lender from 2013—2014 were under 2% of the lender’s annual revenues during the respective years. In addition, the board evaluated his position on the Board of the Missouri History Museum and determined that contributions made by the Company from 2013—2015 to the Missouri History Museum are less than 2% of the Museum’s consolidated gross revenues during the respective years.

All Directors, excluding Michael F. Neidorff, have no direct or indirect material relationship with us except for their role as a Director or stockholder. The Board also broadly considers what it deems to be all relevant facts and circumstances in determining the independence of its members.

 

 

Board of Directors Committees

 

 

Our Board of Directors has established three primary committees: Audit, Compensation, and Nominating and Governance—each of which operates under a charter that has been approved by our Board. Current copies of each committee’s charter are posted on our website, www.centene.com/investors. The composition of these committees is provided in the following table.

 

Board Member   Board of
Directors
  Audit
Committee
  Compensation
Committee
  Nominating and
Governance
Committee

Michael F. Neidorff

  Chairman            

Orlando Ayala

  ü       ü    

Robert K. Ditmore

  Presiding
Director
      Chairman   ü

Frederick H. Eppinger

  ü   ü        

Richard A. Gephardt

  ü            

Pamela A. Joseph

  ü   ü   ü    

John R. Roberts

  ü   Chairman        

David L. Steward

  ü       ü   Chairman

Tommy G. Thompson

  ü       ü   ü

Meetings held in 2015

  17   6   5   1

 

Centene Corporation    9


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

All of our Directors attended 75% or more of the meetings of the Board and of any committees thereof on which they served. Our corporate governance guidelines provide that Directors are expected to attend the 2016 Annual Meeting of Stockholders. All Directors attended the 2015 Annual Meeting of Stockholders.

Our Board of Directors has also established a Government and Regulatory Affairs Committee, which is co-chaired by Richard A. Gephardt and Tommy G. Thompson; a Technology Committee chaired by Orlando Ayala; and a Compliance Committee chaired by Michael Neidorff.

The Compliance Committee’s primary responsibility is to serve as overall compliance oversight of the Company. The Compliance Committee’s responsibilities include, among others:

 

  ¡   review of the compliance program structure;

 

  ¡   remaining informed of compliance program outcomes, including audit results and governmental enforcement activities;

 

  ¡   receiving quarterly reports from the Chief Compliance Officer and other members of management in executive session;

 

  ¡   ensuring independent review of any potential issues, and enforcing appropriate corrective actions;

 

  ¡   reviewing the results of performance audits and monitoring of Medicare operations, as well as effectiveness assessments of the Medicare Compliance Program;

 

  ¡   providing specific guidance and directives to Management for the remediation and implementation of Compliance Program initiatives and updates.

Board of Directors

 

 

Our Board of Directors has responsibility for establishing broad corporate policies and reviewing our overall performance rather than day-to-day operations. The Board’s primary responsibility is to oversee the management of the Company and, in doing so, serve the best interests of the Company and its stockholders. The Board selects, evaluates and provides for the succession of executive officers and, subject to stockholder election, Directors. It reviews and approves corporate objectives and strategies, and evaluates significant policies and proposed major commitments of corporate resources. Management keeps the Directors informed of its activities through regular written reports and presentations at Board and committee meetings.

The Board currently combines the role of Chairman of the Board with the role of Chief Executive Officer, coupled with a Presiding Director position to further strengthen the governance structure. The Board believes this provides an efficient and effective leadership model for the Company. Combining the Chairman and CEO roles fosters clear accountability, effective decision-making, and alignment on corporate strategy. The Board periodically reviews its leadership structure. To assure effective independent oversight, the Board has adopted a number of governance practices, including:

 

  ¡   a strong, independent, clearly-defined Presiding Director role;

 

  ¡   executive sessions of the independent Directors in connection with every Board meeting; and

 

  ¡   annual performance evaluations of the Chairman and CEO by the independent Directors.

Our Board of Directors has appointed Robert K. Ditmore “Presiding Director” to preside at all executive sessions of “non-management” Directors, as defined under the rules of the NYSE. The Presiding Director’s role includes leading the Board’s processes for selecting and evaluating the Chief Executive Officer and presiding at all meetings of the Board at which the Chairman is not present, including executive sessions of the independent Directors.

 

10    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

Our corporate governance guidelines require the Board to conduct an annual self-evaluation to determine whether it and its committees are functioning effectively. The Nominating and Governance Committee receives comments from all directors and reports annually to the Board with an assessment of the Board’s performance. This is discussed with the full Board following the end of each fiscal year. The assessment focuses on the Board’s contribution to the Company and specifically focuses on areas in which the Board or management believes that the Board could improve.

Audit Committee

 

 

The Audit Committee’s responsibilities include:

 

  ¡   appointing, retaining, evaluating, terminating, approving the compensation of, and assessing the independence of our independent registered public accounting firm;

 

  ¡   overseeing the work of our independent registered public accounting firm, including through the receipt and consideration of certain reports from the independent registered public accounting firm;

 

  ¡   reviewing and discussing with management and the independent registered public accounting firm our annual and quarterly financial statements and related disclosures;

 

  ¡   monitoring our internal control over financial reporting, disclosure controls and procedures and code of business conduct and ethics;

 

  ¡   overseeing our internal audit function;

 

  ¡   discussing our risk management policies;

 

  ¡   establishing policies regarding hiring employees from our independent registered public accounting firm and procedures for the receipt and retention of accounting-related complaints and concerns;

 

  ¡   meeting independently with our internal auditing staff, independent registered public accounting firm and management; and

 

  ¡   preparing the Audit Committee report required by SEC rules.

The Board has determined that John R. Roberts, Frederick H. Eppinger and Pamela A. Joseph are “audit committee financial experts” as defined in Item 407(d)(5) of Regulation S-K and that each member of the Audit Committee is “financially literate” under the applicable NYSE rules.

Compensation Committee

 

 

The Compensation Committee oversees our activities in the area of compensation and benefits (generally with regard to all employees and specifically with regard to our Named Executive Officers, or NEOs, identified in the Summary Compensation Table, as well as other officers) and reviews and makes recommendations concerning compensation-related matters to be submitted to the Board and/or stockholders for approval. The Board has determined that each of the members of the Compensation Committee is “independent,” as defined under the rules of the NYSE. The Compensation Committee’s responsibilities include:

 

  ¡   evaluating compensation policies and practices to determine if they may be influencing employees to take excessive risks;

 

Centene Corporation    11


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

  ¡   annually reviewing and approving corporate goals and objectives relevant to our Chief Executive Officer’s compensation;

 

  ¡   reviewing and making recommendations to the Board with respect to our Chief Executive Officer’s compensation;

 

  ¡   reviewing and approving, or making recommendations to the Board with respect to, the compensation of our other executive officers;

 

  ¡   overseeing an evaluation of our senior executives;

 

  ¡   overseeing and administering our equity incentive plans; and

 

  ¡   reviewing and making recommendations to the Board with respect to Director compensation.

Members of management assist the Compensation Committee in its responsibilities by providing recommendations for the Compensation Committee’s approval concerning the design of our compensation program for our executive officers other than our Chief Executive Officer, including our NEOs, as well as recommended award levels. The design of our compensation program for our Chief Executive Officer is recommended by the Compensation Committee and approved by the Board without any approval of the Chairman, who is the Company’s Chief Executive Officer.

The Compensation Committee considered information and data regarding executive compensation supplied by management and by Towers Watson, a compensation and benefits consultant retained by management. In addition, Exequity, LLC, an independent compensation consulting group, has been engaged directly by the Compensation Committee to provide advice with respect to base salaries, bonus targets and long term incentives for our NEOs.

In 2015, the Company utilized Towers Watson to provide advice with respect to the base salaries, bonus targets and long term incentives of our officers, including our NEOs. The consultants analyzed the compensation levels of the NEOs of the industry peer group developed by Towers Watson for the most recently completed fiscal year. As discussed under the CD&A, the Compensation Committee considered this information, along with a variety of other factors, in reviewing our executive compensation in 2015.

The Compensation Committee has reviewed the independence of each of Towers Watson and Exequity in light of SEC rules and NYSE listing standards, including the following factors: (1) other services provided to us by the consulting firm; (2) fees paid by us as a percentage of consulting firm’s total revenue; (3) policies or procedures maintained by the consulting firm that are designed to prevent a conflict of interest; (4) any business or personal relationships between the compensation consultant and a member of the Compensation Committee; (5) any company stock owned by the compensation consultant; and (6) any business or personal relationships between our executive officers and the senior advisor. The Compensation Committee discussed these considerations and concluded that the compensation consultants’ work for the committee does not raise any conflict of interest.

The Compensation Committee delegates to management the authority to grant certain stock options and restricted stock units under the 2012 Stock Incentive Plan. Our Chief Executive Officer is authorized to issue awards (other than to himself) of up to 60,000 shares to any newly hired executive and up to 24,000 shares to any one person during a calendar year, and is required to report any such grants to the Compensation Committee at the following Compensation Committee meeting. The delegation of authority may be terminated by the Compensation Committee at any time and for any reason. All internal promotions and equity grants to a corporate officer and all offers to any “Executive Officer” (as defined by Rule 3b-7 under the Exchange Act) require Compensation Committee approval.

 

12    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

Nominating and Governance Committee

 

 

The Nominating and Governance Committee’s responsibilities include:

 

  ¡   identifying individuals qualified to become members of the Board;

 

  ¡   recommending to the Board the persons to be nominated for election as Directors and to each of the Board’s committees;

 

  ¡   reviewing and making recommendations to the Board with respect to management succession planning;

 

  ¡   reviewing and recommending to the Board corporate governance principles; and

 

  ¡   overseeing an annual evaluation of the Board’s performance.

 

 

Director Candidates

 

 

The process followed by the Nominating and Governance Committee to identify and evaluate Director candidates includes requests to Board members and others for recommendations, meetings from time to time to evaluate biographical information and background material relating to potential candidates and interviews of selected candidates by members of the Nominating and Governance Committee and the Board. As previously noted, pursuant to the terms of the July 2015 definitive merger agreement to acquire the issued and outstanding shares of Health Net, Inc., we are obligated following closing to appoint to our Board of Directors, a current member of the Health Net board of directors. The Board of Directors anticipates that this new director would be appointed as a Class I director, standing for election at the 2017 Annual Meeting of Stockholders. Upon nomination and election of a new Director by the Board during any year, that Director is expected to be nominated for election at the next annual meeting.

In considering whether to recommend any particular candidate for inclusion in the Board’s slate of recommended Director nominees, the Nominating and Governance Committee will apply the criteria set forth in our Corporate Governance Guidelines. These criteria include the candidate’s integrity, business acumen, knowledge of our business and industry, age, experience, diligence, conflicts of interest and the ability to act in the interests of all stockholders. The Nominating and Governance Committee does not assign specific weights to particular criteria and no particular criterion is a prerequisite for each prospective nominee. We believe that the backgrounds and qualifications of our Directors, considered as a group, should provide a composite mix of experience, knowledge and abilities that will allow the Board to fulfill its responsibilities.

Board membership should reflect diversity in its broadest sense, including persons diverse in background, geography, perspective, gender, and ethnicity. The Board is particularly interested in maintaining a mix that includes the following backgrounds:

 

  ¡   Public company governance

 

  ¡   Healthcare

 

  ¡   Service and insurance industry

 

  ¡   Companies with revenues greater than $1 billion

 

  ¡   Public accounting

 

  ¡   Community involvement

 

Centene Corporation    13


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

  ¡   Investment banking

 

  ¡   International

 

  ¡   Financial services

 

  ¡   Technology

 

  ¡   Organizational development

 

  ¡   Political and regulatory relationships

 

  ¡   Experience as a Chief Executive Officer

Stockholders may recommend individuals to the Nominating and Governance Committee for consideration as potential Director candidates by submitting their names, together with appropriate biographical information and background materials to Nominating and Governance Committee, c/o Corporate Secretary, Centene Corporation, 7700 Forsyth Boulevard, St. Louis, Missouri 63105. Assuming that appropriate biographical and background material has been provided on a timely basis in accordance with the procedures set forth in our By-Laws, the Nominating and Governance Committee will evaluate stockholder-recommended candidates by following substantially the same process and applying substantially the same criteria as it follows for candidates submitted by others.

Stockholders also have the right under our By-Laws to directly nominate Director candidates, without any action or recommendation on the part of the Nominating and Governance Committee or the Board, by following the procedures set forth under “Submission of Future Stockholder Proposals” of this proxy statement.

 

 

Communicating with Independent Directors

 

 

The Board will give appropriate attention to written communications that are submitted by stockholders and other interested parties and will respond as appropriate. The Chairman of the Nominating and Governance Committee, with the assistance of our Chief Executive Officer, is primarily responsible for monitoring communications from stockholders and other interested parties and for providing copies or summaries to the other Directors as he or she considers appropriate. Under procedures approved by a majority of the independent Directors, communications are forwarded to all Directors if they relate to important substantive matters and include suggestions or comments considered to be important for the Directors to know.

Stockholders and interested parties who wish to send communications on any topic to the Board should address such communications to Board of Directors c/o Corporate Secretary, Centene Corporation, 7700 Forsyth Boulevard, St. Louis, Missouri 63105. Any stockholder or interested party who wishes to communicate directly with our Presiding Director, or with our non-employee Directors as a group, should also follow the foregoing method.

 

14    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

 

Director Compensation

 

 

The following table summarizes the compensation of our non-employee Directors for the fiscal year ended December 31, 2015:

 

Name   Fees Earned or
Paid in Cash
($)
    Stock
Awards
($) 1
    Option
Awards
($) 1
    All Other
Compensation
($) 2
   

Total

($)

 

Orlando Ayala

  $ 115,000      $ 205,999      $      $ 4,290      $ 325,289   

Robert K. Ditmore

           375,999               4,290        380,289   

Frederick H. Eppinger

           330,999               29,290        360,289   

Richard A. Gephardt

           345,999               19,566        365,565   

Pamela A. Joseph

           330,999               4,290        335,289   

John R. Roberts

    30,000        330,999               29,290        390,289   

David L. Steward

           345,999               29,290        350,289   

Tommy G. Thompson

           345,999               14,290        360,289   
  1 The amounts reported as Stock Awards and Option Awards reflect the grant date fair value of grants made during the current year under the 2012 Stock Incentive Plan and Non-Employee Directors Deferred Stock Compensation Plan. Assumptions used in the calculation of this amount for the fiscal year ended December 31, 2015 are included in footnote 15 to the Company’s audited financial statements for the fiscal year ended December 31, 2015 included in the Company’s Annual Report on Form 10-K filed with the SEC on February 22, 2016. There can be no assurance that the grant date fair value of Stock Awards or Option Awards will ever be realized.

 

  2 All other compensation for Mr. Eppinger, Mr. Roberts and Mr. Steward reflects charitable contributions of $25,000, for Mr. Gephardt reflects charitable contributions of $15,276, and for Mr. Thompson reflects charitable contributions of $10,000 made or pledged during 2015 under the Company’s Board of Directors Charitable Matching Gift Program. All Other Compensation also includes group excess liability insurance policy premiums paid by the Company for all Directors.

Non-employee Directors currently receive a quarterly retainer fee of $31,250, provided that the Director elects 100% payment pursuant to the Company’s Non-Employee Directors Deferred Stock Compensation Plan to be paid in company stock upon retirement or termination from the Board. Directors not making this election receive a quarterly retainer fee of $25,000. In addition, the Chairman of the Audit Committee receives a quarterly retainer fee of $7,500, the Chairman of the Compensation Committee received a quarterly fee of $5,000, and the Chairman of the Nominating and Governance Committee, Government and Regulatory Affairs Committee, and Technology Committee each receives a quarterly fee of $3,750. The Company also pays a quarterly retainer fee of $6,250 to the Presiding Director of the Board. All cash fees are eligible for deferral under the Non-Employee Directors Deferred Stock Compensation Plan. Expense recognized in conjunction with the deferred stock election is included in the “Stock Awards” column in the Director Compensation Table above.

Each new non-employee Director, as of the date on which such Director is first elected to the Board, is granted an option under our 2012 Stock Incentive Plan to purchase 20,000 shares of our common stock vesting in three equal annual installments commencing on the first anniversary of the grant date. In April 2015, each member of the Board received a grant of 2,910 restricted shares of our common stock. The restricted shares vest on the April 2016 annual meeting of stockholders, subject to meeting Board of Director meeting attendance conditions.

The Board of Directors has approved the Board of Directors Charitable Matching Gift Program. Under the program, the Company will match a Board member’s qualifying charitable donations of up to $25,000 per calendar year. Charitable donations must be made to a qualified tax exempt U.S. organization under the Internal Revenue Code Section 501(c)(3) and within the Company’s charitable contribution guidelines. The Company also provides a group excess liability insurance policy at no cost to the Directors.

 

Centene Corporation    15


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

PROPOSAL ONE: ELECTION OF DIRECTORS

 

The following table shows the number of shares covered by exercisable and unexercisable options and unvested Restricted Stock Units (RSUs) held by our non-employee Directors on December 31, 2015:

 

     Option Awards     Stock Awards  
Name   Number of
Securities
Underlying
Unexercised
Options
(Exercisable)
    Number of
Securities
Underlying
Unexercised
Options
(Unexercisable)
    Number of
Shares or
Units of
Stock That
Have Not
Vested
 

Orlando Ayala

    20,000               2,910   

Robert K. Ditmore

                  2,910   

Frederick H. Eppinger

                  2,910   

Richard A. Gephardt

                  2,910   

Pamela A. Joseph

    20,000               2,910   

John R. Roberts

    10,000               2,910   

David L. Steward

                  2,910   

Tommy G. Thompson

                  2,910   

Directors are reimbursed for all reasonable expenses incurred in connection with their service. Directors who are also our employees receive no additional compensation for serving on our Board of Directors.

 

16    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL TWO: ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION

 

 

Proposal Two: Advisory Resolution to Approve Executive Compensation

 

 

At our 2015 annual meeting of stockholders, our stockholders approved the Company’s executive compensation. Pursuant to Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we are again holding an advisory vote on the Company’s executive compensation, as described in this proxy statement (commonly referred to as “say-on-pay”). In accordance with the results of the vote we conducted at the 2011 Annual Meeting on the frequency of say-on-pay votes, we plan to present a say-on-pay vote every year.

We encourage stockholders to review the Compensation Discussion and Analysis included in this proxy statement. Our executive compensation program has been designed to implement the Company’s compensation philosophy of paying for performance by making decisions based on promoting the Company’s corporate mission statement and creating long term stockholder value. This philosophy is evidenced by the following:

 

  ¡   We provide a significant part of executive compensation in the form of at-risk annual incentive and long term incentive compensation; for example, we have withheld or reduced payments under our incentive programs when financial measures have not been fully achieved.

 

  ¡   Our annual incentive and long term incentive opportunities are substantially based on corporate financial measures closely correlated with achieving long term stockholder value, such as earnings per share, revenue growth targets, pre-tax operating margins and total shareholder return. Annual and long term incentive opportunities also reflect the impact to the current year income for new contracts awarded that drive future revenue growth and take into account the costs associated with the contract procurements which occur prior to revenue generation.

 

  ¡   We provide a mix of short term and long term and cash and non-cash compensation that we believe allows us to strike a balance between offering competitive executive compensation packages, motivating our executives without fostering excessive risk-taking and linking Executive Officer compensation with the creation of long term stockholder value.

The Board of Directors strongly endorses the Company’s executive compensation program and recommends that stockholders vote in favor of the following resolution:

RESOLVED, that the stockholders approve the compensation of those NEOs listed in the Summary Compensation Table of this proxy statement, who we refer to in this proxy statement as the NEOs, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission (SEC), including the Compensation Discussion and Analysis and the tabular and narrative disclosure included herein under “Information about Executive Compensation”.

Because the vote is advisory, it will not be binding upon the Board of Directors or the Compensation Committee and neither the Board of Directors nor the Compensation Committee will be required to take any action as a result of the outcome of the vote on this proposal. The Compensation Committee strongly considers the views of the Company’s shareholders when making compensation decisions. Additionally, the Compensation Committee monitors the results of the annual advisory “say-on-pay” proposal and incorporates such results as one of many factors considered in connection with the discharge of its responsibilities. Please see the Compensation Discussion and Analysis section of this Proxy Statement for a more detailed discussion of the actions the Committee took during 2015 based on shareholder feedback.

The Board recommends a vote “FOR” the approval of the compensation of the NEOs, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the SEC.

 

Centene Corporation    17


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

PROPOSAL THREE: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

Proposal Three: Ratification of Appointment of Independent Registered Public Accounting Firm

 

 

KPMG LLP audited our financial statements for the fiscal year ended December 31, 2015. The Audit Committee has appointed KPMG LLP to serve as our independent registered public accounting firm for the current fiscal year, and we are asking stockholders to ratify this appointment. Stockholder ratification of this selection is not required by our By-Laws or other applicable legal requirements. Our Board of Directors is, however, submitting the selection of KPMG LLP to stockholders for ratification as a matter of good corporate practice. In the event that stockholders fail to ratify the selection, the Audit Committee will consider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee, in its discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if the Audit Committee believes that a change would be in our and our stockholders’ best interest.

We expect that representatives of KPMG LLP will be present at our Annual Meeting of Stockholders to answer appropriate questions. They will have the opportunity to make a statement if they desire to do so.

The affirmative vote of the holders of a majority of the votes cast at the meeting is being sought to ratify the selection of KPMG LLP as our independent registered public accounting firm for the current fiscal year. The Board recommends that stockholders vote “FOR” the ratification of the selection of KPMG LLP to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2016.

The following table discloses the aggregate fees billed in 2015 and 2014 by KPMG LLP, our independent registered public accounting firm ($ in thousands):

 

     KPMG
     2015   2014

Audit Fees

  $4,005   $3,530

Audit-Related Fees

  205   205

Tax Fees

   

All Other Fees

    600

Audit-related fees in 2015 and 2014 consist primarily of fees for operational control reviews. All Other fees in 2014 consisted primarily of fees for compliance assessment services.

The Audit Committee has adopted policies and procedures relating to the approval of all audit, audit-related, tax and other services that are to be performed by our independent registered public accounting firm. This policy generally provides that the Company will not engage its independent registered public accounting firm to render audit, audit-related, tax or other services unless the service is specifically approved in advance by the Audit Committee or the engagement is entered into pursuant to one of the pre-approval procedures described below.

From time to time, the Audit Committee may pre-approve specified types of services that are expected to be provided to the Company by its independent registered public accounting firm during the next 12 months. Any such pre-approval is detailed as to the particular service or type of services to be provided and is also generally subject to a maximum dollar amount.

 

18    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

PROPOSAL THREE: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

The Audit Committee has also delegated to the Chairman of the Audit Committee the authority to approve audit audit-related, tax or other services to be provided to the Company by its independent registered public accounting firm. Any approval of services by the Chairman of the Audit Committee pursuant to this delegated authority is reported on at the next meeting of the Audit Committee. All audit, audit-related and other fees for 2015 and 2014 were pre-approved by the Audit Committee or the Audit Committee Chairman, and no fees were paid under the de minimis exception to the audit committee pre-approval requirements.

 

Centene Corporation    19


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

AUDIT COMMITTEE REPORT

 

 

Audit Committee Report

 

 

The Audit Committee operates under a written charter adopted by the Company’s Board of Directors. The charter, which was last amended in February of 2009, outlines the Audit Committee’s duties and responsibilities. The Audit Committee reviews the charter annually and works with the Board of Directors to amend the charter based on the Audit Committee’s evolving responsibilities. The Audit Committee charter is available on the Company’s website at www.centene.com/investors/corporate-governance.

The Audit Committee of the Company’s Board of Directors consists of three non-employee directors who are independent under the rules of the NYSE, the rules of the SEC and the Company’s Standards for Director Independence. All of the Audit Committee members are considered Audit Committee Financial Experts as defined by the SEC. The Audit Committee assists the Board of Directors in its oversight of the accounting and financial reporting process of the Company. Specifically, the Audit Committee has responsibility for providing independent objective oversight of the accounting and financial reporting process of the Company, selecting and evaluating the independent registered public accounting firm, which reports directly to the Audit Committee and oversees the performance of the Company’s internal audit function.

Management has the primary responsibility for the preparation of the Company’s financial statements and the overall reporting process, for maintaining adequate internal control over financial reporting and, with the assistance of the Company’s internal auditors, for assessing the effectiveness of the Company’s internal control over financial reporting. The Company’s independent registered public accounting firm is responsible for performing an independent audit of the Company’s financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States)(the “PCAOB”), expressing an opinion as to the conformity of the financial statements with generally accepted accounting principles in the United States of America, and auditing management’s assessment of the effectiveness of internal control over financial reporting. KPMG LLP has served as the Company’s independent registered public accounting firm since 2005.

Management represented to the Audit Committee that the financial statements were prepared in accordance with generally accepted accounting principles and that there were no material weaknesses in its internal control over financial reporting. The Audit Committee met and held discussions with management and KPMG LLP to review and discuss the financial statements and the Company’s internal control over financial reporting. The Audit Committee has also discussed with KPMG LLP the firm’s judgments as to the quality and the acceptability of the Company’s financial reporting and such other matters as are required to be discussed by PCAOB Auditing Standard No. 16, Communication with Audit Committees. KPMG LLP also provided the Audit Committee with the written disclosures and the letter required by applicable requirements of the PCAOB regarding the independent accountant’s communications with the Audit Committee concerning independence. The Audit Committee has discussed with KPMG LLP their independence with respect to the Company, including a review of audit and non-audit fees and services and concluded that KPMG LLP is independent.

 

20    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

AUDIT COMMITTEE REPORT

 

In fulfilling its oversight responsibilities for reviewing the services performed by KPMG LLP, the Audit committee has the sole authority to select, evaluate and replace the outside auditors. The Audit Committee discusses the overall scope of the annual audit, the proposed audit fee, and annually evaluates the qualifications, performance and independence of KPMG LLP as independent registered public accountants and the performance of its lead audit partner. The Audit Committee meets regularly with the internal auditors and independent registered public accounting firm, with and without management present, to discuss the results of their respective examinations, the evaluation of the Company’s internal control over financial reporting and the overall quality of the Company’s accounting.

Based upon the review and discussions with the Company’s management and KPMG LLP referred to above, and its review of the representations and information provided by management and KPMG LLP, the Audit Committee recommended to the Board that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 for filing with the Securities and Exchange Commission. The Committee also reappointed KPMG LLP to serve as the Company’s independent registered public accounting firm for 2016.

AUDIT COMMITTEE

John R. Roberts, Chair

Frederick H. Eppinger

Pamela A. Joseph

 

Centene Corporation    21


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

INFORMATION ABOUT EXECUTIVE COMPENSATION

 

 

Information About Executive Compensation

 

 

Compensation Committee Report

 

 

The Compensation Committee has reviewed and discussed the “Compensation Discussion and Analysis” with the Company’s management. Based on such review and discussions, the Compensation Committee recommended to the Board of Directors that the “Compensation Discussion and Analysis” be included in this proxy statement and our annual report on Form 10-K.

COMPENSATION COMMITTEE

Robert K. Ditmore, Chair

Orlando Ayala

Pamela A. Joseph

David L. Steward

Tommy G. Thompson

 

22    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

 

Compensation Discussion and Analysis (CD&A)

 

 

This CD&A describes the principles, objectives, and compensation policies and arrangements of our executive compensation program which is generally applicable to each of our senior officers. This CD&A focuses primarily on our Chairman & CEO and the other executive officers included in the Summary Compensation Table, whom we collectively refer to in this proxy as our NEOs. For 2015, our NEOs were:

 

  ¡   Michael F. Neidorff, Chairman, President and Chief Executive Officer

 

  ¡   William N. Scheffel, Executive Vice President, Chief Financial Officer and Treasurer

 

  ¡   K. Rone Baldwin, Executive Vice President, Markets

 

  ¡   Carol E. Goldman, Executive Vice President & Chief Administrative Officer

 

  ¡   Jesse N. Hunter, Executive Vice President, Products

The contents of this CD&A are organized as follows:

 

SECTION 1—

2015 Executive Summary

       

SECTION 2—

2015 Compensation Decisions

 

• Alignment of Pay and Performance

 
 

 

• Pay Mix

 
 

• Review

 
 

• Base Salaries

 
 

• Annual Cash Incentive Plan

 
 

• Annual Cash Incentive Payout

 
 

• Long Term Incentive Awards

 
 

• 2014 PSU Performance Evaluation

 
   

• 2013-2015 Cash LTIP Award Payouts

   

SECTION 3—

Compensation Philosophy

 

• Results of the April 2015 “Say-on-Pay” Vote & Changes to the Compensation Program in 2015

 
 

 

• Overview of the Compensation Program

 
 

• Competitive Pay Philosophy

 
 

–  Healthcare Industry Managed Care Peer Group

 
 

–  General Industry High-Performing Peer Group

 
 

• Benchmarking Methodology

 
 

• Base Salaries

 
 

• Annual Cash Incentive

 
 

• Long Term Incentives

 
 

• Cash LTIP Award Performance Targets

 
   

• Other Benefits

   

SECTION 4—

Other Compensation

Policies and Information

 

• Stock Ownership Guidelines

 
 

 

• Pledging Policy

 
 

 

• Risk Disclosure

 
 

• Employment Contracts, Termination of Employment Arrangements, and Change in Control Arrangements

 
 

–  CEO Employment Agreement

 
 

–  Severance and Change in Control Agreements

 
   

• Deductibility of Executive Compensation

   

 

Centene Corporation    23


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

COMPENSATION DISCUSSION AND ANALYSIS

 

 

SECTION 1—2015 Executive Summary

 

 

We compete for business and talent with publicly held managed care organizations (including Aetna, Inc., Anthem, Inc., CIGNA Corp., Health Net, Inc., Humana, Inc., Molina Healthcare, Inc., UnitedHealth Group Inc. and WellCare Health Plans, Inc.) and with regional and local for-profit and not-for-profit organizations. Our strong execution and management of government sponsored programs has resulted in our achieving significant growth rates and total returns for our shareholders.

In 2015, our performance included:

 

  ¡   Premium and service revenues of $21.3 billion, an increase of 36% over 2014.

 

  ¡   Diluted earnings per share (EPS) of $2.89, an increase of 30% over 2014.

 

  ¡   Total operating cash flows of $658 million.

 

  ¡   Return on Equity of 18%.

 

  ¡   Stock price increase of 27%.

The Company’s stock price compound annual growth rate (CAGR) compares to the S&P Supercomposite Managed Healthcare Index (S&P SMHI) as follows:

 

     % Increase   Centene
% of
S&P
SMHI
Increase
     Centene   S&P
SMHI
 
1 Year       27%   20%   135%
3 Year   48%   32%   150%
5 Year   39%   27%   144%

Our three year Compound Annual Growth Rates (CAGR) have been:

 

  ¡   Premium and service revenues of 40%;

 

  ¡   Diluted EPS of 52%; and

 

  ¡   Stock Performance of 48%.

In addition, during 2015 our market capitalization grew to over $7.9 billion.

LOGO

 

LOGO

 

LOGO

 

 

24    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

 

SECTION 2—2015 Compensation Decisions

 

 

Alignment of Pay and Performance

 

 

In 2015, the Company continued to balance aggressive revenue growth organically and through acquisitions while continuing to improve pre-tax margins, which is a key part of our strategy to promote long term shareholder value in a competitive business environment. As the Compensation Committee reviewed our NEO’s compensation, the Committee considered these aspects in conjunction with our executive compensation program of recognizing pay for performance through the following three primary components:

 

LOGO

In recognition of the Company’s extraordinary 2015 performance, the high growth rate over the past 3 years and the Board of Directors’ acknowledgment of the importance of our CEO’s leadership, the Compensation Committee analyzed his total compensation for the past 10 years and awarded total compensation in 2015 that continues to mirror the tremendous growth in our TSR over the last five years. Our CEO’s total compensation alignment with the Company’s Total Shareholder Return is represented in the following graph:

 

LOGO

 

Centene Corporation    25


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Pay Mix

 

 

Our pay for performance philosophy can be further depicted by the following graph, which represents our total compensation mix. The graph illustrates the 2015 values contained in the Summary Compensation Table as percentages of total compensation. The values in the “All Other Compensation” column of the Summary Compensation Table have been excluded from this illustration.

 

LOGO

Review

 

 

Consistent with our compensation philosophy, the Compensation Committee reviewed the target compensation and respective market data of two peer groups: General Industry (GI) and Healthcare Industry (HCI). The table compares Mr. Neidorff’s target compensation for 2015 (which is different from the disclosure in the “Summary Compensation Table”) to these two peer groups. The review of the data indicated that Mr. Neidorff’s total target 2015 compensation was within the 50th percentile and 75th percentile of the general industry (GI), with data regressed, at $25 billion revenue. The Compensation Committee determined that his target pay was appropriately established to reflect the need for an experienced, seasoned CEO in a high growth company. The HCI peer group and GI peer group are discussed in further detail under section 3 of the CD&A under the headings “Healthcare Industry Managed Care Peer Group” and “General Industry High-Performing Peer Group,” respectively.

 

50th Percentile        75th Percentile

Total Target

($ in millions)

   Revenue Analysis        Total Target
($ in millions)
   Revenue Analysis

$12.2

  

HCI at $25 billion

    

$14.3

  

HCI at $25 billion

$14.2

  

HCI at $50 billion

    

$16.2

  

HCI at $50 billion

$14.9

  

GI at $25 billion

    

$18.7

  

Centene1

$18.7

  

Centene1

    

$18.8

  

GI at $25 billion

$19.2

  

GI at $50 billion

    

$24.1

  

GI at $50 billion

  1  The $18.7 million total Centene target represents $1.2 million of annualized base pay, $1.8 million of annual target cash incentive, $15.7 million of long term incentive awards.

 

26    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

A similar analysis of peer data sets is performed of the other NEOs’ compensation. The Compensation Committee reviews the performance of each individual and grants increases in base salary and RSUs based on these results.

Base Salaries

 

 

In December 2014, the Compensation Committee evaluated 2015 base salaries and took into account the Company’s 2015 estimated revenue in excess of $20 billion. In 2015, Towers Watson compared our NEOs’ base salaries to market data, and on average, our base salaries for 2015 were between the 50th and 75th percentile of the healthcare industry peer group and of the general industry peer group. Adjustments to base salaries are determined based on merit and market data.

The NEOs were paid competitive base salaries determined by the evaluation of multiple factors: business results for the prior year, individual performance, as well as the market value for each specific job. Since Centene is a pay for performance Company, only 6% of the Chief Executive Officer’s and, on average, 13% of the other NEOs’ compensation is fixed.

Annual Cash Incentive Plan

 

 

The Compensation Committee assigned an annual cash incentive plan target opportunity of 150% of salary for the CEO and 75% of salary for the other NOEs based on a review of industry data, as discussed in Section 3: Compensation Pay Philosophy. The Compensation Committee rewards NEOs with an Annual Cash Incentive bonus for achieving the Company’s EPS objective. The Committee assesses how each NEO contributed to achieving this EPS objective and other pre-determined objectives approved by the Compensation Committee earlier in the year. For 2015, the Committee determined that 80% of the incentive target will be aligned with the diluted EPS target, and the remaining 20% will be aligned with individual performance objectives, with a maximum payout of 200% of target. The Compensation Committee follows a two step process to determine the bonus earned each year:

 

  1. Achievement of EPS Objective. In December 2014, the Compensation Committee determined that if the company reached its 2015 EPS target of $2.60, then a bonus would be paid at target based on each NEO’s contribution to that target. In addition, the Compensation Committee also determined that if the Company exceeded EPS of $2.68, the Company may pay at 160% of target. Since the Company’s 2015 diluted EPS from continuing operations were $2.89 (111% of target), or $3.03 excluding $0.14 of Health Net merger related expenses (117% of target), the Compensation Committee determined to pay the EPS objective component of the Annual Cash Incentive at 200% of target.

 

  2. Evaluation of Individual Performance. In addition, management and the Compensation committee assessed each NEO’s individual performance against pre-determined goals. If the individual performance goals were met, exceeded or not met, then the individual performance component of the Annual Cash Incentive equaled, exceeded or was less than the target. A summary of each NEO’s individual performance, along with their total 2015 Annual Cash Incentive follows.

 

Centene Corporation    27


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Annual Cash Incentive Payout

 

 

 

Name   Individual Performance    2015
Annual
Cash
Incentive
($)
     % of
Target
Paid
 

Michael F. Neidorff

 

• Exceeded 2015 Premium & Service Revenues and Diluted EPS guidance provided in December 2014.

 

• Increased margin expansion from 2.99% to 3.4% for 2015.

 

• Drove a 27% increase in the stock price during 2015, expanding market capitalization to over $7.9B.

 

• Pending regulatory approval, negotiated purchase of Health Net, Inc. to expand presence in California and the Medicare market and enter the government services market increasing estimated revenue of the company to over $40 billion in 2016.

   $ 3,600,000         200

William N. Scheffel

 

• Exceeded consolidated financial performance targets including revenue growth and earnings.

 

• Identified and began transitioning responsibilities to CFO successor.

   $ 900,000         160

K. Rone Baldwin

 

• Met revenue, membership and margin targets for Health Plans in 2015.

 

• Enhanced effectiveness of Medical Management Group by improving HEDIS scores and improving Health Benefits Ratio.

 

• Launched Medicaid expansions in three states, doubled Marketplace membership and achieved 3 Stars in all Medicare states.

   $ 800,000         171

Carol E. Goldman

 

• Filled approximately 9,000 positions in 2015.

 

• Improved Engagement Survey results by increasing participation to 92% and increasing overall engagement score to 67%.

 

• Implemented various Total Rewards strategies resulting in retention of key staff and a reduction in turnover of 10% from the previous year.

   $ 900,000         200

Jesse N. Hunter

 

• Exceeded Specialty Company revenue and earnings targets.

 

• Created three new Specialty Company opportunities in existing markets.

 

• Won 100% of re-procurements and 62% of new procurements in 2015.

   $ 945,000         200

Based on the Company meeting its diluted EPS goal, increasing pre-tax income and increasing Premium and Service Revenues from continuing operations to $21.3 billion, the Compensation Committee reviewed the Chief Executive Officer’s performance during 2015 and recommended to the Board of Directors that an annual bonus of $3.6 million be awarded to Mr. Neidorff. The bonus, which was 200% of his target, is representative of the Company’s outstanding year and represents the maximum award. In addition, other NEOs received an annual bonus that ranged from 160% to 200% of target based on an evaluation of 2015 performance.

 

28    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Long Term Incentive Awards

 

 

The Compensation Committee granted long term incentives to our NEOs in December 2015 based on a review of industry data, as follows:

 

  ¡   Performance based RSUs (PSUs)—The target metrics for 2016-2018 are pre-tax margin (75% weight), and compound annual revenue growth (25% weight). Target metric achievement will result in the attainment of 100% of the PSUs granted. If earned, PSUs will vest in February 2019.

 

  ¡   Service based RSUs—33.3% vest annually based on service to the Company.

 

  ¡   Cash Long Term Incentive Plan (LTIP)—based on meeting the performance criteria above for the 3 year performance period (2016-2018) as well as a Relative Total Shareholder Return (TSR) objective.

2014 PSU Performance Evaluation

 

 

In December 2014, the NEOs were awarded PSUs with a performance target of diluted EPS of $2.60. In February 2016, the Compensation Committee reviewed the 2015 diluted EPS of $2.89 achieved compared to the EPS target of $2.60 and determined that the performance condition on the December 2014 awards was achieved at 100% (the target, with no maximum). 33.3% of earned PSUs vested in February 2016 with the remaining 66.7% vesting evenly over the second and third anniversaries of the grant date.

2013-2015 Cash LTIP Award Payouts

 

 

In December of 2012, the Compensation Committee established the following metrics, targets and weights for the 2013-2015 Cash LTIP. The Compensation Committee has the discretion to evaluate the metrics on an “as adjusted” basis, and excluded certain one-time transaction costs in evaluating the pre-tax margin metric criteria. The company met or exceeded all three targets as shown below with a total percentage payout of 165.9% of the target:

 

     Metric Criteria     Weight     2013-2015
Actual (As
Adjusted)
    Metric
Payout of
Target
    Weighted
Payout
 
  Threshold     Target     Maximum          

Pre-tax Margin

    2.5     3.0     4.0     37.5     3.1     109.0     40.9

Compound Annual Revenue Growth Rate (CAGR)

    15.0     20.0     25.0     12.5     40.4     200.0     25.0

HCI Peer Relative Total Shareholder Return (TSR) Percentile Rank

    25th        50th        90th        50.0     93rd        200.0     100.0

TOTAL

                            100%                        165.9
                                                         

The amounts earned by each NEO are reflected in the table below:

 

Name   Payout ($)

Michael F. Neidorff

  $2,985,750

William N. Scheffel

    1,103,069

K. Rone Baldwin

       704,969

Carol E. Goldman

       796,200

Jesse N. Hunter

       912,313

 

Centene Corporation    29


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

COMPENSATION DISCUSSION AND ANALYSIS

 

 

SECTION 3—Compensation Philosophy

 

 

The following principles guide the Company’s compensation philosophy:

 

  ¡   Pay for Performance—Our overall compensation philosophy is to pay for performance. An executive’s compensation is directly linked to performance and the achievement of both Company and individual goals. Superior performance and the achievement of goals results in higher compensation.

 

  ¡   Create Long Term Stockholder Value—Both performance-based and service-based stock awards with meaningful retention requirements are used to encourage sustained shareholder value creation.

 

  ¡   Foster a Culture of Risk Management and Compliance—A portion of NEO compensation is based on meeting individual goals that align with our corporate mission statement and promote a culture of compliance with rules, regulations and the Company’s vision and values and rewarding those who mitigate business risks.

 

  ¡   Attract and Retain Top Executive Talent—We offer competitive pay to attract, motivate and retain industry executives with the skills and experience to drive superior long term Company performance in a high growth company.

Results of the April 2015 “Say-on-Pay” Vote & Changes to the Compensation Program in 2015

 

 

The Compensation Committee monitors the results of the annual advisory “say-on-pay” proposal and considers such results as one of many factors in connection with the discharge of its responsibilities. At our April 2015 Annual Meeting, approximately 87% of our shareholders voted to approve our fiscal 2014 executive compensation program.

While shareholders expressed a wide variety of views about executive compensation, we valued the insights we received as we reached out to gain a more thorough understanding of their comments. As a result of feedback from our shareholders, the Compensation Committee made the following changes to the compensation program for 2015:

 

  ¡   Annual Cash Incentive Plan—80% of each award will be aligned with the diluted EPS target, and the remaining 20% of each award will be aligned with individual performance objectives. The Annual Cash Incentive Award will be calculated as follows, with a maximum payout of 200% of target:

 

LOGO

 

  ¡   Performance Based RSUs—Performance targets for awards granted during the December 2015 cycle must meet pre-determined revenue growth and pre-tax margin metrics for a three-year performance period. If the metrics are met, the awards will vest at the end of the three-year performance period.

 

30    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Overview of the Compensation Program

 

 

The Compensation Committee establishes and administers the executive compensation philosophy and program and assists the Board of Directors in the development and oversight of all aspects of executive compensation. Presented in the table below are highlights of our compensation practices:

 

 

What We Do
 

ü Pay for Performance A significant portion of our NEOs’ compensation is tied to performance with clearly articulated financial goals.

 

ü Annual Compensation Risk Assessment We regularly analyze risks related to our compensation program and conduct a broad risk assessment annually.

ü Competitive Compensation Each component of the NEOs’ annual total direct compensation is targeted to the 50th percentile for both the Health Care Industry peer group and the General Industry peer group.

 

ü Stock Ownership Requirements We maintain rigorous stock ownership requirements for our directors, executives and other members of senior management. Our CEO’s requirement is 5x annual base pay; other NEOs’ requirements are 2.5x annual base pay.

ü Equity Grants Reward Future Performance 50% of annual RSU grants vest ratably over a three-year period. Beginning in 2015, PSU grants vest at the end of the three-year period based on two three-year performance metrics.

 

ü Clawbacks We can recover performance-based cash and equity incentive compensation paid to executives in various circumstances.

ü Formula Based Annual Incentive Plan Beginning in 2015, awards under the Annual Cash Incentive plan are formula based.

 

ü Independent Compensation Consultant The Compensation Committee retains Exequity to advise the Committee on executive compensation matters.

ü Tally Sheets Tally sheets and wealth accumulation analyses for each NEO are reviewed annually before making compensation decisions.

 
What We Don’t Do
 

û Excessive Risk-Taking in Our Compensation Programs The Long Term Incentive Plans use multiple performance measures, capped payouts and other features intended to minimize the incentive to take overly risky actions.

 

û No Hedging or Pledging Directors and executives are prohibited from hedging, pledging or engaging in any derivatives trading with respect to company stock.

û No Tax Gross-ups There are no tax “gross-ups” for perquisites or excise tax gross-ups in the event of a change of control related termination.

 

û No Backdating or Repricing of Stock Options Stock options are never backdated or issued with below-market exercise prices. Re-pricing of stock options without stockholder approval is expressly prohibited.

û No Single-Trigger Employment Agreements Any cash payments in executive employment agreements are subject to a “double-trigger” change in control condition.

 

 

Centene Corporation    31


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Competitive Pay Philosophy

 

 

Centene must leverage its compensation and benefit programs to attract the best talent to compete and achieve aggressive operating objectives. Therefore, Centene views both private equity firms and competitors with larger revenue bases as significant competition for talent. Centene also recognizes that our Company is a source for these firms and competitors to recruit talent if the appropriate compensation programs are not in place at Centene.

For the components of target total compensation, the Compensation Committee’s competitive objectives are for:

 

  ¡   base salaries to approximate the 50th percentile of similarly-sized organizations, based on revenues. The 50th percentile will be targeted in most instances; however, up to the 75th percentile is considered when recruiting talent from significantly larger companies and private equity firms or when the experience of the executive dictates a higher base salary;  

 

  ¡   annual bonus targets to approximate the 50th percentile of similarly-sized organizations; and  

 

  ¡   long term incentive targets to approximate the 50th percentile of similarly-sized organizations.  

The goal of these objectives is that based on individual performance, actual total compensation will fall at the 50th percentile of total market based compensation for both the healthcare industry peer group and the general industry peer group for expected performance and between the 50th and 75th percentile based on extraordinary performance.

In order to achieve these objectives, the Compensation Committee establishes target, market-based total compensation levels (e.g., base salary, annual bonus target and long term incentives) from market data from two different peer groups:

A. Healthcare Industry Managed Care Peer Group

 

 

Using the Standard and Poor’s Global Industry Classification System (GICS) codes, Towers Watson analyzed the managed care industry and determined there are three key segments in the industry:

 

  ¡   Managed Healthcare Companies

 

  ¡   Healthcare Facilities

 

  ¡   Healthcare Services

Based on further review by Towers Watson, the following companies were included in the Company’s Healthcare Industry Managed Care Peer Group for use in determining compensation for NEOs for 2016.

 

LOGO

 

32    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

B. General Industry High-Performing Peer Group

 

 

Since there is a market for executive talent both within and outside our industry, we also look at comparable companies that replicate the high growth rates the Company has achieved. Therefore, the market data the Compensation Committee utilizes includes not only the managed healthcare industry peer group of 16 companies, but also a general industry peer group of 35 companies also developed by Towers Watson. The median revenue of these 35 companies was $13 billion with revenue ranging from $8 billion to $40 billion. The Compensation Committee believes that including this broader range of companies is likely to provide a more representative depiction of the overall competitive market for talent, as evidenced by several of our executives who came from companies outside of our industry. Towers Watson developed this group from its Executive Compensation Database and determined that each company in the group would meet at least three of the following criteria:

 

  ¡   5-year average return on invested capital > 10%

 

  ¡   5-year revenue CAGR > 10%

 

  ¡   5-year EPS CAGR > 10%

 

  ¡   5-year TSR CAGR > 10%

Benchmarking Methodology

 

 

The Compensation Committee engaged Towers Watson to gather, analyze and summarize the market data from the Towers Watson Executive Compensation Database for the CEO and the other four NEOs. In addition, the Compensation Committee reviewed additional data sources from Exequity in determining the compensation for the CEO. As mentioned previously, Exequity was retained independently by the Compensation Committee to provide recommendations for the CEO’s compensation.

For this analysis, we size adjusted both the healthcare and general industry peer data to $25 billion in revenues. The Compensation Committee also reviewed the data adjusted to $50 billion to reflect the estimated future revenue based on our growth pattern combined with the Health Net acquisition.

All elements of compensation are valued and reviewed in evaluating the relative competitiveness of our compensation practices against both the market data and the Compensation Committee’s competitive objectives. In addition, the Compensation Committee annually reviews a tally sheet for each NEO, which includes the current value of all outstanding equity-based awards, benefits and perquisites. The Compensation Committee uses the tally sheets to analyze each NEO’s base salary, annual incentive target and long term incentive opportunity in relation to the market and each component of compensation as a percentage of total compensation.

Base Salaries

 

 

While reviewing market data from Exequity and Towers Watson to determine appropriate annual base salaries, the Compensation Committee also considers:

 

  ¡   the Chief Executive Officer’s compensation recommendations for all other NEOs;

 

  ¡   the scope of responsibility, experience, time in position and individual performance of each officer, including the Chief Executive Officer;

 

  ¡   each executive’s leadership performance and potential to enhance long term stockholder value; and

 

  ¡   internal equity.

 

Centene Corporation    33


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Annual Cash Incentive

 

 

The Compensation Committee rewards NEOs with an Annual Cash Incentive bonus for achieving the Company’s EPS objective. The Committee assesses how each NEO contributed to achieving this EPS objective and other pre-determined objectives approved by the Compensation Committee in early February of the current year. The Compensation Committee follows a two-step process to determine the amount of bonus earned each year:

 

  1. The Company must meet a specific EPS objective during the year before any payments may be made. If the Company does not meet its threshold performance, no payments are made. For example, in 2012, the Company did not reach its threshold EPS objective and, accordingly, no annual bonuses were paid.

 

  2. In addition, each NEOs’ individual performance is assessed by Management and the Compensation Committee against the pre-determined objectives. If these pre-determined objectives were met, exceeded or not met, then the annual bonus could equal, exceed or be less than target, respectively. Included in each NEO’s determination is the achievement of an individual goal related to risk management.

Individual awards under our bonus plan are approved by the Compensation Committee based primarily upon:

 

  ¡   business performance versus our business plan;

 

  ¡   the effectiveness of each executive’s leadership performance and potential to enhance long term stockholder value;

 

  ¡   targeted bonus amounts, which are based upon market data; and

 

  ¡   the recommendation of the Chief Executive Officer (for all NEOs other than the CEO).

Long Term Incentives

 

 

Our long term incentive compensation is designed to attract and retain key executives, build an integrated management team, reward for innovation and appropriate risk-taking, balance short term planning with long term successes and align executive and stockholder interests. TSR, revenue growth, and pre-tax operating margin targets as well as competitive market practices are all used by the Compensation Committee in determining long term incentives.

These long term incentives take the form of the following:

 

  ¡   Performance Based Restricted Stock Units (PSUs) which are based on meeting pre-determined performance targets (pre-tax margin and revenue growth), vest at the end of the three-year performance period.

 

  ¡   Restricted Stock Units (RSUs) which vest over three years.

 

  ¡   Cash Long Term Incentive Plan (Cash LTIP) which is based on meeting three year TSR, pre-tax margin and revenue growth metrics.

Long term incentives are provided both through equity (PSUs and RSUs) and cash, ensuring that the maximum number of shares of common stock granted in any calendar year (excluding shares granted in connection with an acquisition) does not exceed a level associated with competitive practice. Excluding acquisitions, the Company does not annually grant equity compensation exceeding 2% of the outstanding shares of the Company. PSUs and RSUs are normally granted at the annual December Compensation Committee meeting, but may also be awarded at other Compensation

 

34    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Committee meetings for a promotion, extraordinary performance, a newly hired executive or as determined by the Compensation Committee.

Cash LTIP Award Performance Targets

 

 

The Compensation Committee utilizes the Cash LTIP, which is a three year performance program, to complement the stock incentive plan, manage dilution and supplement the number of shares available under the Company’s stock incentive plan. Each NEO is awarded a grant at the beginning of the three-year cycle based on the following targets:

 

  ¡   Chairman & CEO—150% of Prior Year’s Annual Salary

 

  ¡   Other NEOs—100% of Prior Year’s Annual Salary

Cash awards are paid annually, if earned, after completion of each 3 year performance cycle, and targets are announced annually prior to the beginning of each 3 year performance cycle.

The Compensation Committee sets performance targets at levels it believes to be rigorous and challenging. The performance criteria may include any of the metrics identified in the plan document. The Compensation Committee may determine that the performance parameters used to measure the appropriate pay out include or exclude items which are deemed extraordinary. These items include but are not limited to those stated in the plan document.

In order for a NEO to earn a Cash LTIP payout, at least one of the following metric thresholds must be achieved: pre-tax margin percentage, revenue CAGR percentage or TSR relative to the healthcare industry peer group. These metrics are applicable for the 2014-2016 cycle (awarded in December 2013), the 2015-2017 cycle (awarded in December 2014), and the 2016-2018 cycle (awarded in December 2015).

Other Benefits

 

 

We provide our NEOs with a defined contribution 401(k) retirement program which is the same program that is generally provided to all our employees. We also provide our NEOs with a non-qualified deferred compensation plan to make up for matching contributions that are capped by compensation limits imposed on qualified retirement plans under the Internal Revenue Code. We do not provide our NEOs with a defined benefit retirement program. We also do not provide retiree medical coverage to our NEOs, with the exception of Mr. Neidorff, as specified in his employment agreement.

With respect to most other benefits, the benefits provided to NEOs and other executive officers are comparable to those provided to the majority of salaried and hourly Company employees. We require all NEOs to have their tax returns prepared or reviewed by an independent certified public accounting firm. Due to this requirement, costs related to these services are paid by the Company. In addition, each NEO has the option to use a financial advisor for fees that do not exceed $15,000 annually in total for both tax preparation and financial advisement.

The Board of Directors believes that additional security is required for the position of Chairman, President and Chief Executive Officer and other NEOs. Pursuant to a policy implemented by our Board, Mr. Neidorff is required to use Company provided aircraft for all air travel. We also have an aircraft time sharing agreement with Mr. Neidorff that permits him to reimburse us for incremental costs when he uses the aircraft for personal travel. In addition, we provide home security services to Mr. Neidorff. Mr. Neidorff’s personal use of Company aircraft and home security services are fully taxable to him and are not grossed up to cover his personal income tax liability. Home security services are also provided to our NEOs, and these costs are also fully taxable to them and are not grossed up to cover any personal income tax liability.

 

Centene Corporation    35


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

COMPENSATION DISCUSSION AND ANALYSIS

 

 

SECTION 4—Other Compensation Policies and Information

 

 

Stock Ownership Guidelines

 

 

Centene utilizes stock ownership guidelines for our NEOs, corporate officers and Board of Directors. We believe that ownership of our stock helps align the interests of our executives and stockholders and encourages executives to act in a manner that is expected to increase stockholder value. The stock ownership guidelines for our officers are as follows:

 

     Minimum Ownership Requirement
as a Multiple of Base Salary
 

Chairman, President and Chief Executive Officer

    5x   

Executive Vice Presidents

    2.5x   

Senior Vice Presidents

    2x   

Plan & Specialty Company Presidents and Corporate Vice Presidents

    1x   

The Compensation Committee annually reviews the stock ownership levels of the Board of Directors and all officers. Future stock awards take into consideration the executive’s level of attainment of the suggested stock ownership amount. The Compensation Committee may elect to award the annual incentive to an executive in stock instead of cash if the suggested stock ownership amount is not achieved.

Officers who fail to achieve these ownership levels may not be eligible to receive any stock-based awards until they achieve their required ownership level. Shares owned directly by the officer (including those held as a joint tenant or as tenant in common), unvested RSUs, shares owned in a self-directed IRA, “phantom shares” held in the deferred compensation plan and certain shares owned or held for the benefit of a spouse or minor children are counted toward the guidelines. Options and unearned PSUs are not counted toward the ownership guidelines.

The Board has established a policy requiring executive officers to retain ownership of the shares received from the vesting or payout of any RSU award granted under our stock incentive plan (net of any shares used to satisfy tax obligations) for one year following such vesting or payout. An executive may substitute the tax basis of the shares under restriction for other shares held outright.

As of the close of the last fiscal year and the date of this report, all NEOs subject to the ownership guidelines are in compliance with the guidelines. At $65.81 per share (the December 31, 2015 closing stock price), ownership percentages of our executive officers were as follows:

 

Name   Ownership as a Multiple of
2015 Base Salary
 

Michael F. Neidorff

    210.4x   

William N. Scheffel

    14.7x   

K. Rone Baldwin

    12.7x   

Carol E. Goldman

    16.6x   

Jesse N. Hunter

    22.7x   

Our stock ownership guidelines for members of our Board of Directors require them to own 40,000 shares of common stock. As of December 31, 2015, all Directors were in compliance with this requirement.

 

36    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Pledging Policy

 

 

In February 2014, the Board of Directors amended the Company’s insider trading policy to prohibit pledging of shares by executive officers and members of the Board of Directors. As of February 26, 2016, all executive officers and directors were in compliance with this policy.

Risk Disclosure

 

 

The Compensation Committee is aware of the consequences to companies that have not appropriately balanced risk and rewards in executive compensation. The Compensation Committee believes that the emphasis on long term performance in the stock incentive plan and the Cash LTIP results in an overall compensation program that does not reward excessive risk-taking for the Company. Risk is further limited by the ownership guidelines mentioned previously and a clawback provision that provides that any cash bonuses that are paid from the annual incentive plan or Cash LTIP or vesting of performance based RSUs that are a result of material financial impropriety (as defined by the Audit Committee of the Board of Directors), including but not limited to financial restatements due to these improprieties, may result in any officers becoming obligated to pay back the amount to the Company.

The Company’s compensation strategy is intended to mitigate risk by emphasizing long term compensation and financial performance measures correlated with growing stockholder value rather than rewarding shorter performance and payout periods. A recent review of the Company’s compensation programs did not identify any programs that unduly incentivize employees to take any excessive risks.

Employment Contracts, Termination of Employment Arrangements, and Change in Control Arrangements

 

 

CEO Employment Agreement

 

 

Michael F. Neidorff serves as Chairman of our Board of Directors and our President and Chief Executive Officer pursuant to an employment agreement dated November 8, 2004 (as amended). Under this agreement, we paid Mr. Neidorff a 2015 annual salary of $1.2 million and will pay Mr. Neidorff a 2016 annual salary of $1.5 million, which is subject to an annual review by our Board of Directors. Mr. Neidorff is eligible for a target annual incentive of 150% of base salary. The agreement also awarded Mr. Neidorff 2,000,000 RSUs as of November 8, 2004. Of these RSUs, 60% vested in 2009 and the remaining 40% vested ratably from 2010 through 2014. The RSUs and all of the related shares of common stock shall be distributed to Mr. Neidorff on the later of (a) January 15 of the first calendar year following termination of Mr. Neidorff’s employment or (b) the date that is six months after Mr. Neidorff’s “separation of service” as defined in the Code.

In 2013, the Board of Directors and Mr. Neidorff agreed to extend the contract beyond the previous termination date to ensure continuity in the business and an orderly transition of leadership in 2017. The amendment eliminated the “single trigger” for severance payment following a change of control by amending the definition of “good reason” to eliminate his ability to terminate his employment for any reason during the one month period beginning on the six-month anniversary of a change in control of the Company. It also eliminated tax gross-up benefits for excise taxes payable upon change in control; extended the term of the employment agreement to December 31, 2017; and provided for the grant of 60,000 restricted stock units.

 

Centene Corporation    37


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

COMPENSATION DISCUSSION AND ANALYSIS

 

Mr. Neidorff has agreed not to compete with us or solicit any of our employees during the term of his employment and for 12 months thereafter. Mr. Neidorff’s employment may be terminated by the Company for cause or permanent disability, or by Mr. Neidorff for good reason. If Mr. Neidorff is terminated by the Company without cause or if he terminates for good reason, he is entitled to receive salary continuation for a period of 36 months or the remaining term of the agreement, whichever is shorter (but not less than six months), lifetime health and dental coverage (to which he would be entitled under the Consolidated Omnibus Budget Reconciliation Act of 1985, or COBRA), lifetime life insurance coverage, lifetime medical insurance for him and his eligible dependent, full acceleration of any unvested stock options or other equity awards held by him, and acceleration of a portion of unvested RSUs awarded pursuant to the agreement based on certain stipulations. Upon a change in control during the term of this agreement, any unvested RSUs and any unvested stock options or other equity awards held by Mr. Neidorff will vest in full.

Severance and Change in Control Agreements

 

 

K. Rone Baldwin, Carol E. Goldman, Jesse N. Hunter and William N. Scheffel serve as executive officers pursuant to executive severance and change in control agreements (the agreements, as amended), and their 2016 annual salaries are $650,000, $625,000, $650,000 and $750,000, respectively.

The agreements generally provide that, if within 24 months following a change in control (as defined in the agreements), the executive’s employment is terminated by the Company other than for cause (as defined in the agreements) or by the executive for good reason (as defined in the agreements), the executive will receive a lump sum cash payment equal to the sum of (1) an amount equal to 24 months of salary, (b) the average of the executive’s last two annual bonuses multiplied by two, and (c) a prorated annual bonus for the year in which the termination occurs. The executive also will receive 18 months of medical coverage. The executive’s existing equity awards will vest in full at the time of a change in control.

The agreements also generally provide that, if an executive’s employment is terminated by the Company other than for cause or by the executive for good reason in the absence of a change in control, the executive will receive 12 months of salary continuation, a prorated annual bonus for the year in which the termination occurs, 12 months of medical coverage and 12 months of continued vesting of the executive’s existing equity awards. These NEOs amended their agreements in February 2015 to eliminate tax gross-up benefits for excise taxes payable upon a change in control.

Under the terms of any new executive employment agreement, if any parts or amounts payable under the agreement are deemed to be “excess parachute payments” within the meaning of Section 280G of the Code or similar provision, the executive will be required to pay any additional taxes.

In the agreements, the executives agree to non-competition and non-solicitation provisions that extend through the first anniversary of termination of employment, unless the termination was due to a “hostile takeover” as defined in the agreement. In 2012, the agreements were amended to eliminate the non-compete and non-solicitation provisions under any change in control.

The Board has determined that it is in our best interests and our stockholders’ to assure that we will have the continued dedication of the executive, notwithstanding the possibility, threat, or occurrence of a change in control. The Board believes it is imperative to diminish the inevitable distraction of the executive by virtue of the personal uncertainties and risks created by a pending or threatened change in control, to encourage the executive’s full attention and dedication to the Company, and to provide

 

38    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

COMPENSATION DISCUSSION AND ANALYSIS

 

the executive with compensation and benefits arrangements upon a change in control which (i) will satisfy the executive’s compensation and benefits expectations and (ii) are competitive with those of other major corporations.

Deductibility of Executive Compensation

 

 

Section 162(m) of the Code generally disallows a tax deduction to a publicly traded company for compensation in excess of $1 million paid to its Chief Executive Officer and its three other most highly compensated Executive Officers, excluding the Chief Financial Officer. Some types of compensation, including qualified performance based compensation, will not be subject to the deduction limit if specified requirements are met. In general, we structure and administer our stock incentive plans in a manner intended to comply with the performance based exception to Section 162(m). Additionally, we intend that our Annual Cash Incentive Plan complies with the performance based exception to Section 162(m). Nevertheless, there can be no assurance that compensation attributable to awards granted under our stock incentive plans, our Annual Cash Incentive Plan or our Long Term Incentive Plan will be treated as qualified performance based compensation under Section 162(m).

Section 162(m)(6), which was enacted as part of the Patient Protection and Affordable Care Act (PPACA), amended the Code to limit the amount that certain healthcare insurers and providers, including the Company, may deduct for compensation to any employee in excess of $500,000 for a tax year beginning after December 31, 2012. This legislation does not create any exceptions for performance-based compensation. The Compensation Committee did not consider the impact of this legislation when reviewing and determining executive compensation. However, the Compensation Committee reserves the right to use its judgment to authorize compensation payments that may be subject to the limit when the Compensation Committee believes such payments are appropriate and in the best interests of our stockholders, after taking into consideration changing business conditions and the performance of its employees. Upon the completion of the merger with Health Net, Inc., we expect to be subject to this legislation in 2016 with respect to the former Health Net employees. We expect Centene, as a whole, to be subject to the limitation in 2017.

 

Centene Corporation    39


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

EQUITY COMPENSATION PLAN INFORMATION

 

 

Equity Compensation Plan Information

 

 

The following table provides information as of December 31, 2015, about the securities authorized for issuance under our equity compensation plans, consisting of our 1998 Stock Incentive Plan, 1999 Stock Incentive Plan, 2000 Stock Incentive Plan, 2003 Stock Incentive Plan, 2012 Stock Incentive Plan and 2002 Employee Stock Purchase Plan.

 

Plan Category   (a)
Number of
Securities to
be Issued
Upon Exercise
of Outstanding
Options,
Warrants and
Rights
    (b)
Weighted-
Average
Exercise
Price of
Outstanding
Options,
Warrants
and Rights
    (c)
Number of Securities
Remaining Available
For Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in Column
(a))
 

Equity compensation plans approved by stockholders

    4,799,411      $ 11.88        3,390,351   

Equity compensation plans not approved by stockholders

                    

Total

    4,799,411                3,390,351   

The number of securities in column (a) includes 677,408 options with a weighted-average remaining life of 2 years and 4,122,003 shares of restricted stock and restricted stock units.

The number of securities in column (c) includes 861,980 shares available for future issuance under the 2002 Employee Stock Purchase Plan.

 

40    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

SUMMARY COMPENSATION TABLE

 

 

Summary Compensation Table

 

 

The following table summarizes the compensation of our NEOs for the fiscal years ended December 31, 2015, 2014 and 2013. Additional descriptions of each component of compensation for our NEOs is included elsewhere in this Proxy Statement under the caption, “Compensation Discussion and Analysis.”

 

Name &
Principal Position
  Year    

Salary

($)

   

Bonus

($)

    Performance
Based Stock
Awards
($)
   

Service
Based
Stock
Awards

($)

   

Total Stock

Awards

($)1

   

Non-Equity
Incentive Plan
Compensation

($)

   

All Other

Compensation

($)

    Total
($)
 

Michael F. Neidorff

    2015      $ 1,200,000      $      $ 6,165,600      $ 6,165,600      $ 12,331,200      $ 6,585,750 2    $ 638,153 3    $ 20,755,103   

Chairman, President and Chief Executive Officer

    2014        1,200,000        3,600,000        6,965,000        6,965,000        13,930,000               570,387        19,300,387   
    2013        1,200,000        3,000,000        5,773,800        4,246,500        10,020,300               292,638        14,512,938   
                                 
                                                                       

William N. Scheffel

    2015        750,000                      3,782,022        3,782,022        2,003,069 2      76,398 4      6,611,489   

Executive Vice President and Chief Financial Officer

    2014        720,000        1,000,000        1,488,750        1,488,750        2,977,500               69,216        4,766,716   
    2013        690,000        900,000        716,500        716,500        1,433,000               40,120        3,063,120   
                                 
                                                                       

K. Rone Baldwin

    2015        625,000               994,000        994,000        1,988,000        1,504,969 2      40,290 4      4,158,259   

Executive Vice President, Markets

    2014        575,000        550,000        992,500        992,500        1,985,000               42,256        3,152,256   
    2013        425,000        450,000        859,800        859,800        1,719,600               46,374        2,640,974   
                                                                       

Carol E. Goldman

    2015        600,000               923,000        923,000        1,846,000        1,696,200 2      76,576 4      4,218,776   

Executive Vice President and Chief Administrative Officer

    2014        550,000        750,000        1,091,750        1,091,750        2,183,500               72,667        3,556,167   
    2013        500,000        525,000        716,500        716,500        1,433,000               44,333        2,502,333   
                                 
                                 
                                                                       

Jesse N. Hunter

    2015        630,000               1,136,000        1,136,000        2,272,000        1,857,313 2      83,866 4      4,843,179   

Executive Vice President, Products

    2014        600,000        825,000        1,488,750        1,488,750        2,977,500               67,312        4,469,812   
    2013        570,000        600,000        716,500        716,500        1,433,000               42,346        2,645,346   
                                 
                                                                       
  1  The amounts reported as Stock Awards for Mr. Neidorff, Mr. Baldwin, Ms. Goldman and Mr. Hunter reflect the grant date fair value of grants made during the current year under the 2012 Stock Incentive Plan. The amounts reported as Stock Awards for Mr. Scheffel reflect the fair value of modifications made to his existing stock awards to accelerate the vesting of unvested awards upon his retirement.

 

    Assumptions used in the calculation of this amount for the fiscal year ended December 31, 2015 are included in footnote 15 to the Company’s audited financial statements for the fiscal year ended December 31, 2015 included in the Company’s Annual Report on Form 10-K filed with the SEC on February 22, 2016. There can be no assurance that the grant date fair value of Stock Awards will ever be realized. Stock awards granted in December 2015, 2014 and 2013 to the NEOs consisted of performance based awards and service based awards. If the maximum performance metrics are achieved, the grant date fair value of the performance awards would be $12,331,200 for Mr. Neidorff, $1,988,000 for Mr. Baldwin, $1,846,000 for Ms. Goldman, and $2,272,000 for Mr. Hunter. The Summary Compensation Table reflects the probable amount of shares to be earned under the performance condition.

 

  2 2015 Non-Equity Incentive Plan Compensation includes both the annual cash incentive and the cash LTIP award payouts.

 

  3  All other compensation includes $243,938 of personal use of Company provided aircraft. Pursuant to the policy established by our Board, our Chairman, President and Chief Executive Officer is required to use Company provided aircraft for all travel, a taxable benefit to Mr. Neidorff pursuant to the applicable Internal Revenue Service regulations. For flights on corporate aircraft, the cost is calculated based on a cost-per-flight-hour charge developed by a nationally recognized and independent service, offset by any timeshare payments by the executive. This charge reflects the operating and periodic maintenance costs of the aircraft, crew travel expenses and other miscellaneous costs. We have an aircraft time sharing agreement with Mr. Neidorff under which he is permitted to reimburse us for the incremental costs of his personal use of corporate aircraft consistent with FAA regulations. The other amounts included in other compensation for Mr. Neidorff include $150,790 in life insurance benefits, $137,435 in nonqualified deferred compensation match, $74,040 in security services, and $31,950 in tax preparation and financial advisor fees, Company entertainment event tickets, and 401(k) match.

 

  4  All other compensation includes nonqualified deferred compensation match, 401(k) match, tax preparation and financial advisor fees, security services, as well as life insurance benefits. The other amounts included in other compensation for Mr. Scheffel and Mr. Hunter include $45,388 and $36,399, respectively, in nonqualified deferred compensation match.

 

Centene Corporation    41


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

GRANTS OF PLAN-BASED AWARDS TABLE

 

 

Grants of Plan-Based Awards Table

 

 

The following table provides information on 2015 grants of RSUs under the 2012 Stock Incentive Plan, as well as 2015 cash-based grants under the Cash LTIP and Annual Cash Incentive Plan to each of our NEOs. The grant date fair values of these stock awards are included in the Summary Compensation Table. The vesting provisions of the equity awards are included in the footnotes to the Outstanding Equity Awards at Fiscal Year-End Table.

 

Name   Grant
Date
   

Estimated Future Payouts Under

Non-Equity Incentive Plan
Awards1

    Estimated Future Payouts
Under Equity Incentive Plan
Awards: Number of Shares of
Stock or Units (#)2
   

All Other
Stock
Awards:
Number of
Shares of

Stock or
Units (#)3

   

Grant Date

Fair

Value of
Stock
Awards ($)4

 
    Threshold
($)
   

Target

($)

    Maximum
($)
    Threshold     Target     Maximum      

Michael F. Neidorff

    12/16/2015      $ 112,500      $ 1,800,000      $ 3,600,000                                  $   
    12/16/2015        787,500        2,250,000        4,500,000                                      
    12/16/2015                             52,500        105,000 5      210,000        105,000        12,331,200   

William N. Scheffel

    12/30/2015                                                  56,668        3,782,022   

K. Rone
Baldwin

    12/15/2015        39,063        625,000      $ 1,250,000                                      
    12/15/2015        227,500        650,000        1,300,000                                      
    12/15/2015                             8,750        17,500 5      35,000        17,500        1,988,000   

Carol E. Goldman

    12/15/2015        37,500        600,000        1,200,000                                      
    12/15/2015        218,750        625,000        1,250,000                                      
    12/15/2015                             8,125        16,250 5      32,500        16,250        1,846,000   

Jesse N.
Hunter

    12/15/2015        39,375        630,000        1,260,000                                      
    12/15/2015        227,500        650,000        1,300,000                                      
    12/15/2015                             10,000        20,000 5      40,000        20,000        2,272,000   
  1 “Estimated Future Payouts Under Non-Equity Incentive Plan Awards” reflect grants made under the Cash LTIP and Annual Cash Incentive Plan.

 

  2  “Estimated Future Payouts Under Equity Incentive Plan Awards: Number of Shares of Stock or Units” represent PSU grants.

 

  3  “All Other Stock Awards: Number of Shares of Stock or Units” represent RSU grants for Mr. Neidorff, Mr. Baldwin, Ms. Goldman and Mr. Hunter. The amount reported for Mr. Scheffel reflects the fair value of modifications made to his existing stock awards to accelerate the vesting of unvested awards upon his retirement.

 

  4  Assumptions used in the calculation of the Grant Date Fair Value are included in footnote 15 to the Company’s audited financial statements for the fiscal year ended December 31, 2015, included in the Company’s Annual Report on Form 10-K filed with the SEC on February 22, 2016. There can be no assurance that the Grant Date Fair Value of Stock Awards will ever be realized.

 

  5  Equity incentive grants contain a performance condition based upon our 2016 to 2018 cumulative pre-tax margin and compound revenue growth. For performance between the threshold and the target or the target and the maximum, the number of RSUs earned will be interpolated.

 

42    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE

 

 

Outstanding Equity Awards at Fiscal Year-End Table

 

 

The following table shows the number of shares covered by exercisable and unexercisable options and unvested RSUs held by our NEOs on December 31, 2015:

 

Name   Option Awards     Stock Awards  
  Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
    Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
    Option
Exercise
Price
($)1
    Option
Expiration
Date
    Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)2
    Market Value
of Shares or
Units of
Stock
That Have
Not Vested
($)
    Equity
Incentive
Plan Awards:
Number of
Unearned
Shares, Units
or Other
Rights That
Have Not
Vested
(#)2
    Equity
Incentive
Plan Awards:
Market Value
of Unearned
Shares, Units
or Other
Rights That
Have Not
Vested ($)
 

Michael F. Neidorff

    172,068             $ 12.60        12/12/2016        100,000 3    $ 6,581,000        60,000 7    $ 3,948,600   
                                  93,334 4      6,142,311        105,000 8      6,910,050   
                                  140,000 5      9,213,400                 
                                  105,000 6      6,910,050                 

William N. Scheffel

                                16,668 9      1,096,921                 
                                  20,000 10      1,316,200                 
                                  30,000 11      1,974,300                 
                                                         

K. Rone Baldwin

                                20,000 9      1,316,200        17,500 8      1,151,675   
                                  13,334 10      877,511                 
                                  20,000 11      1,316,200                 
                                  17,500 12      1,151,675                 

Carol E. Goldman

    6,000               12.60        12/12/2016        16,668 9      1,096,921        16,250 8      1,069,413   
                                  14,666 10      965,169                 
                                  22,000 11      1,447,820                 
                                  16,250 12      1,069,413                 

Jesse N. Hunter

    24,000               12.60        12/12/2016        16,668 9      1,096,921        20,000 8      1,316,200   
      20,000               8.42        4/28/2018        20,000 10      1,316,200                 
                                  30,000 11      1,974,300                 
                                  20,000 12      1,316,200                 
  1  The option price for each grant is equal to the previous day’s closing market price.

 

  2  Upon a change in control, any unvested shares will vest in full.

 

  3  The RSUs vest on December 11, 2016.

 

  4  The RSUs vest in two equal installments on the anniversary of the grant date beginning on December 10, 2016.

 

  5  46,668 of the RSUs vested on February 9, 2016. The remaining RSUs vest in two equal installments on the anniversary of the grant date beginning on December 10, 2016.

 

  6  The RSUs vest in three equal installments on the anniversary of the grant date beginning on December 16, 2016.

 

  7  The RSUs vest and become non-forfeitable on the later of (i) May 14, 2016, or (ii) the date that Mr. Neidorff has identified a successor Chief Executive Officer. Vested RSUs shall be converted into shares of Centene common stock and distributed to Mr. Neidorff on the later of (i) the January 15 following the year in which Mr. Neidorff’s date of termination occurs, or (ii) the date which is six months after Mr. Neidorff’s date of termination.

 

  8  The RSUs are performance stock units vesting when the Company releases 2018 earnings, in 2019. The number of performance stock units vesting over the three installments is predicated on meeting three-year performance conditions.

 

  9  The RSUs vest on December 10, 2016.

 

  10  The RSUs vest in two equal installments on the anniversary of the grant date beginning on December 9, 2016.

 

  11  One-third of the RSUs vested on February 9, 2016. The remaining RSUs vest in two equal installments on the anniversary of the grant date beginning on December 9, 2016.

 

  12  The RSUs vest in three equal installments on the anniversary of the grant date beginning on December 15, 2016.

 

Centene Corporation    43


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

OPTION EXERCISES AND STOCK VESTED TABLE

 

 

Option Exercises and Stock Vested Table

 

 

The following table shows the number of shares of Centene stock acquired by our NEOs in 2015 upon exercise of options or vesting of RSUs:

 

Name    Option Awards    Stock Awards
   Number of Shares
Acquired on Exercise (#)
 

Value Realized

on Exercise ($)

   Number of Shares
Acquired on Vesting (#)
  Value Realized on
Vesting ($)

Michael F. Neidorff

   420,000   $18,729,200    296,666   $16,844,228

William N. Scheffel

        49,666   2,829,853

K. Rone Baldwin

        46,666   2,665,428

Carol E. Goldman

   15,998   812,386    47,000   2,676,825

Jesse N. Hunter

   40   2,298    49,666   2,829,853

 

44    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

NONQUALIFIED DEFERRED COMPENSATION TABLE

 

 

 

Nonqualified Deferred Compensation Table

 

 

Under the Company’s Deferred Compensation Plan, the NEOs may contribute any designated percentage of salary and / or bonus into the plan which serves as an excess savings plan when tax limitations are reached under our tax qualified 401(k) plan. The following table shows the change in the Nonqualified Deferred Compensation balances for our NEOs, as well as the deferral of restricted stock units for Michael Neidorff as discussed in footnote 5, for the fiscal year ended December 31, 2015:

 

Name   Executive
Contributions in
Last FY ($)1
    Registrant
Contributions in
Last FY ($)2
    Aggregate
Earnings
(Losses) in Last
FY ($)3
    Aggregate
Withdrawals /
Distributions ($)
    Aggregate Balance
at Last FYE ($)4
 

Michael F. Neidorff

    $288,069        $136,050        $29,161,651 5      $(471,157     $139,193,316 5 

William N. Scheffel

    575,000        44,315        61,911               1,732,356   

K. Rone Baldwin

                                  

Carol E. Goldman

    36,006        9,658        30,583               632,685   

Jesse N. Hunter

    87,305        35,465        (4,123            800,830   
  1 Executive contributions are included in the Salary column in the Summary Compensation Table.

 

  2  All registrant contributions are included in the All Other Compensation column in the Summary Compensation Table.

 

  3  The Company does not pay above market interest or preferential dividends on investments in the Deferred Compensation Plan. Investment options in the Deferred Compensation Plan are substantially the same as the 401(k) plan, with the exception of the investment in Centene common stock. The returns on the investments available to employees during 2015 ranged from -16% to 27%, with a median return of 0% for the year ended December 31, 2015.

 

  4  The Aggregate Balance at Last Fiscal Year-End column includes money the Company owes these individuals for salaries and incentive compensation they earned in prior years but did not receive because they elected to defer receipt of it and save it for retirement. For fiscal 2015, the amounts described in footnote 1 are included in the Summary Compensation Table as described in footnote 1. For fiscal 2014, the following aggregate amounts of executive contributions were included in the Summary Compensation Table: Mr. Neidorff—$254,769; Mr. Scheffel—$251,497; Ms. Goldman—$34,212; Mr. Hunter—$73,350. For fiscal 2013, the following aggregate amounts of executive contributions were included in the Summary Compensation Table: Mr. Neidorff—$72,000; Mr. Scheffel—$55,154; Ms. Goldman—$49,954; Mr. Hunter—$34,172. For prior years, all amounts contributed by a NEO in such years have been reported in the Summary Compensation Table in our previously filed proxy statements in the year earned, to the extent the executive was named in such proxy statements and the amounts were so required to be reported in such tables.

 

  5  Pursuant to the terms of the grant agreement, the receipt of 2,000,000 restricted stock units vested from 2009 through 2014 have been deferred until retirement. The increase in value during 2015 (aggregate earnings), and the December 31, 2015 market value (balance at last FYE) are presented in the table.

 

Centene Corporation    45


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

 

 

Potential Payments Upon Termination or Change in Control

 

 

The section below describes the payments that may be made to our NEOs upon termination or a change in control. Generally, pursuant to our executive agreements, a change in control is deemed to occur:

 

  ¡   If any individual, entity or group (other than a group which includes the executive) acquires 40% or more of the voting power of our outstanding securities;

 

  ¡   If a majority of the incumbent Board of Directors are replaced. For these purposes, the incumbent Board of Directors means the Directors who were serving as of the effective date of the applicable executive agreement and any individual who becomes a Director subsequent to such date whose election or nomination for election was approved by a majority of such Directors, other than in connection with a proxy contest; or

 

  ¡   Upon the consummation of a merger or consolidation of the Company with another person, other than a merger or consolidation where the individuals and entities who were beneficial owners, respectively, of our outstanding voting securities immediately prior to such merger or consolidation own 50% or more of the then-outstanding shares of the combined voting power of the then-outstanding voting securities of the corporation resulting from such merger or consolidation.

The amounts presented below assume the termination or change in control occurred as of December 31, 2015. The NEOs would receive other payments and benefits to which they were already entitled or vested on such date, including amounts under the Deferred Compensation Plan under the ‘Nonqualified Deferred Compensation Table.’ The applicable agreements are discussed in the CD&A under the heading “Employment Contracts, Termination of Employment Arrangements, and Change in Control Arrangements” included in this proxy statement. The change in control cash payments are subject to the conditions of the “double-trigger” criteria in each of the NEOs’ employment agreements. Additionally, Mr. Scheffel, Ms. Goldman, Mr. Hunter and Mr. Baldwin amended their employment agreements in February 2015 to eliminate tax gross-up benefits for excise taxes payable upon change in control, and therefore, those amounts are excluded from the tables below.

Michael F. Neidorff

 

 

 

Executive Benefits
and Payments Upon
Terminations
 

Voluntary

Termination

   

Involuntary

Not for Cause

or Voluntary

with Good

Reason

Termination

    For Cause
Termination
    Retirement     Death     Disability    

Change in

Control

 

Severance

  $      $ 6,000,000      $      $      $      $      $ 6,000,000   

Pro rata Bonus Payment

           1,800,000                      1,800,000               1,800,000   

Unvested RSUs

           39,705,411                      39,705,411        39,705,411        39,705,411   

Long Term Incentive Plan Payment

           1,800,000               1,800,000        1,800,000        1,800,000        1,800,000   

Welfare Benefits Values

                                5,741,000                 

 

46    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

 

William N. Scheffel

 

 

 

Executive Benefits
and Payments Upon
Terminations
  Voluntary
Termination
    Involuntary
Not for Cause
Termination
    For Cause
Termination
    Death     Disability     Change in
Control
 

Severance

  $      $ 750,000      $      $      $      $ 3,400,000   

Pro rata Bonus Payment

           562,500                             562,500   

Unvested RSUs

           3,071,155               182,030        182,030        4,387,355   

Long Term Incentive Plan Payment

           700,000               700,000        700,000        1,410,000   

Welfare Benefits Values

           16,672               805,000               161,411   

Outplacement

           10,000                             10,000   

K. Rone Baldwin

 

 

 

Executive Benefits
and Payments Upon
Terminations
 

Voluntary

Termination

   

Involuntary

Not for Cause

Termination

   

For Cause

Termination

    Death     Disability    

Change in

Control

 

Severance

  $      $ 625,000      $      $      $      $ 2,250,000   

Pro rata Bonus Payment

           468,750                             468,750   

Unvested RSUs

           3,400,205               188,743        188,743        5,813,261   

Long Term Incentive Plan Payment

           475,000               475,000        475,000        1,000,000   

Welfare Benefits Values

           22,394               567,000               33,591   

Outplacement

           10,000                             10,000   

Carol E. Goldman

 

 

 

Executive Benefits
and Payments Upon
Terminations
 

Voluntary

Termination

   

Involuntary

Not for Cause

Termination

   

For Cause

Termination

    Death     Disability    

Change in

Control

 

Severance

  $      $ 600,000      $      $      $      $ 2,475,000   

Pro rata Bonus Payment

           450,000                             450,000   

Unvested RSUs

           3,257,595               181,504        181,504        5,648,670   

Long Term Incentive Plan Payment

           516,667               516,667        516,667        1,050,000   

Welfare Benefits Values

           23,538               2,011,000               350,735   

Outplacement

           10,000                             10,000   

 

Centene Corporation    47


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

 

Jesse N. Hunter

 

 

 

Executive Benefits
and Payments Upon
Terminations
 

Voluntary

Termination

   

Involuntary

Not for Cause

Termination

   

For Cause

Termination

    Death     Disability    

Change in

Control

 

Severance

  $      $ 630,000      $      $      $      $ 2,710,000   

Pro rata Bonus Payment

           472,500                             472,500   

Unvested RSUs

           3,948,600               220,464        220,464        7,019,689   

Long Term Incentive Plan Payment

           580,000               580,000        580,000        1,170,000   

Welfare Benefits Values

           23,538               3,450,000               355,936   

Outplacement

           10,000                             10,000   

 

48    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

OTHER MATTERS

 

 

Other Matters

 

 

Information About Stock Ownership

 

 

The following table sets forth information regarding beneficial ownership of our common stock as of February 26, 2016 for:

 

  ¡   each person, entity or group of affiliated persons or entities known by us to beneficially own more than 5% of our outstanding common stock;

 

  ¡   each of our NEOs and Directors (three of whom are nominated for re-election); and

 

  ¡   all of our executive officers and Directors as a group.

 

     Amount and Nature of Beneficial Ownership  
Name and Address of Beneficial Owner  

Outstanding

Shares

   

Shares

Acquirable

Within 60 Days

   

Total

Beneficial

Ownership

   

Percent

of Class

 

BlackRock, Inc.

40 East 52nd Street

New York, New York 10022

    11,079,473               11,079,473        9.1   

The Vanguard Group, Inc.

100 Vanguard Blvd.

Malvern, Pennsylvania 19355

    9,314,409               9,314,409        7.7   

Capital World Investors

333 South Hope Street

Los Angeles, CA 90071

    7,281,039               7,281,039        6.0   

Michael F. Neidorff

    1,344,502        2,172,068 1      3,516,570        2.8   

Robert K. Ditmore

    564,297 2      97,105        661,402 3      *   

John R. Roberts

    96,992 4      101,032        198,024 3      *   

Tommy G. Thompson

    85,448        89,861        175,309 3      *   

Jesse N. Hunter

    129,661        44,000        173,661        *   

Pamela A. Joseph

    75,210        84,801        160,011 3      *   

Frederick H. Eppinger

    68,286        78,310        146,596 3      *   

William N. Scheffel

    107,238               107,238        *   

David L. Steward

    6,000        94,326        100,326 3      *   

Orlando Ayala

    64,386        22,910        87,296        *   

Carol E. Goldman

    55,801               55,801        *   

Richard A. Gephardt

    47,366        5,002        52,368 3      *   

K. Rone Baldwin

    47,828               47,828        *   

All Directors and Executive Officers as a group (16 persons)

    2,803,340        2,789,416        5,592,756        4.5   
  * Represents less than 1% of outstanding shares of common stock.

 

  1  Of Mr. Neidorff’s shares acquirable within 60 days, 2,000,000 were granted in the form of RSUs, payable in shares of common stock, pursuant to the executive employment agreement with Mr. Neidorff dated November 8, 2004. 1,200,000 of the shares vested in November 2009 and 160,000 of the shares vested in each of November 2010, 2011, 2012, 2013 and 2014. The RSUs shall be distributed to Mr. Neidorff on the later of (a) January 15 of the first calendar year following termination of Mr. Neidorff’s employment and (b) the date that is six months after Mr. Neidorff’s “separation of service” as defined in the Code.

 

  2 Mr. Ditmore’s outstanding shares include 160,100 shares owned by family members, family partnerships or trusts. Mr. Ditmore disclaims beneficial ownership except to the extent of his pecuniary interest therein.

 

  3 Shares beneficially owned by Messrs. Ditmore, Eppinger, Gephardt, Roberts, Steward, and Thompson and Ms. Joseph include 94,195, 75,400, 2,092, 88,122, 91,416, 86,951 and 61,891, respectively, RSUs acquired through the Non-Employee Directors Deferred Stock Compensation Plan.

 

  4 Mr. Roberts’ outstanding shares include 86,992 shares owned by a revocable trust. Mr. Roberts disclaims beneficial ownership except to the extent of his pecuniary interest therein.

 

Centene Corporation    49


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

OTHER MATTERS

 

As discussed under Compensation Discussion & Analysis, in February 2014, the Board of Directors amended the Company’s insider trading policy to prohibit pledging of shares by executive officers and members of the Board of Directors. As of February 26, 2016, all executive officers and directors were in compliance with this policy.

As of February 26, 2016, there were 121,667,250 shares of our common stock outstanding, net of treasury shares. Beneficial ownership is determined in accordance with the rules of the SEC. To calculate a stockholder’s percentage of beneficial ownership, we include in the numerator and denominator those shares underlying options beneficially owned by that stockholder that are vested or that will vest within 60 days of February 26, 2016. Options held by other stockholders, however, are disregarded in the calculation of beneficial ownership. Therefore, the denominator used in calculating beneficial ownership among our stockholders may differ.

Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, except to the extent authority is shared by spouses under applicable community property laws.

No Director, Executive Officer, affiliate or owner of record, or beneficial owner of more than five percent of any class of our voting securities, or any associate of such individuals or entities, is a party adverse to us or any of our subsidiaries in any material proceeding or has any material interest adverse to us or any of our subsidiaries.

Information with respect to the outstanding shares beneficially owned by BlackRock, Inc. is based on Schedule 13G/A filed with the SEC on January 26, 2016 by such firm. BlackRock, Inc. beneficially owns 11,079,473 shares. Of the shares BlackRock, Inc. owns, it has sole voting power over 10,273,891 shares and sole dispositive power over 11,079,473 shares.

Information with respect to the outstanding shares beneficially owned by The Vanguard Group, Inc. is based on Schedule 13G/A filed with the SEC on February 10, 2016 by such firm. The Vanguard Group, Inc. beneficially owns 9,314,409 shares. Of the shares The Vanguard Group, Inc. owns, it has sole voting power over 116,848 shares and sole dispositive power over 9,187,561 shares.

Information with respect to the outstanding shares beneficially owned by Capital World Investors is based on Schedule 13G/A filed with the SEC on February 12, 2016 by such firm. Capital World Investors beneficially owns 7,281,039 shares. Of the shares Capital World Investors owns, it has sole voting power over 7,281,039 shares and sole dispositive power over 7,281,039 shares.

 

50    Centene Corporation


Table of Contents
2016 NOTICE OF MEETING AND PROXY STATEMENT   

 

OTHER MATTERS

 

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

 

Directors, executive officers and beneficial owners of more than ten percent of our common stock are required by Section 16(a) of the Exchange Act to file reports with the SEC detailing their beneficial ownership of our common stock and other equity securities and reporting changes in such beneficial ownership. We are required to disclose any late filings of such reports. To our knowledge, based solely on our review of copies of reports furnished to us and written representations by the persons required to file these reports that no reports were required, all Section 16(a) filing requirements during 2015 were complied with on a timely basis, except that, due to administrative error, Mr. Gephardt did not timely file a Form 4, reporting a deferred compensation share award of 491 shares, Ms. Brinkley did not timely file a Form 4, reporting a phantom stock acquisition of 274 shares, and Ms. Goldman did not timely file a Form 4, reporting 13 gifts totaling 328,516 shares.

If an executive officer or member of the Board wants to sell shares of the Company’s stock, we require them to sell through a Rule 10b5-1 sales plan in order to afford themselves affirmative defenses, protections and safeguards provided by Rule 10b5-1 promulgated under the Exchange Act.

 

 

Submission of Future Stockholder Proposals

 

 

Under SEC rules, a stockholder who wishes to present a proposal, including nomination of a Director, for inclusion in our proxy statement for our 2017 Annual Meeting of Stockholders must submit the proposal in writing to Keith H. Williamson, our Secretary, at 7700 Forsyth Boulevard, St. Louis, Missouri 63105, before November 14, 2016. SEC rules set standards for the types of stockholder proposals and the information that must be provided by the stockholder making the request.

A stockholder may also submit a proposal to be considered at our 2017 Annual Meeting of Stockholders pursuant to our By-Laws (and not under SEC rules). In that case, the proposal would not be required to be included in our proxy statement for our 2017 Annual Meeting of Stockholders and the proposal must be received by our Secretary not less than 120 days nor more than 150 days before the first anniversary of the 2016 Annual Meeting. This notice must include the information required by the provisions of our By-Laws, a copy of which may be obtained by writing to our Secretary at the address specified above. The deadline for delivery of a stockholder proposal pursuant to our By-Laws would be between November 27, 2016 and December 27, 2016.

We have not set a date for our 2017 Annual Meeting of Stockholders. If the date of our 2017 Annual Meeting of stockholders is advanced or delayed by more than 30 days from April 26, 2017, we shall inform our stockholders, in our earliest possible quarterly report on Form 10-Q, of such change and the new dates for submitting stockholder proposals.

 

Centene Corporation    51


Table of Contents
   2016 NOTICE OF MEETING AND PROXY STATEMENT

 

OTHER MATTERS

 

 

Householding

 

 

Some banks, brokers and other nominee record holders may be participating in the practice of “householding”. This means that only one copy of either the proxy notice or this proxy statement, our 2015 Annual Review and Annual Report on Form 10-K may have been sent to multiple stockholders sharing an address unless the stockholders provide contrary instructions. We will promptly deliver a separate copy of these documents to you if you call, write or e-mail us at:

Centene Corporation

7700 Forsyth Boulevard

St. Louis, Missouri 63105

Attn: Keith H. Williamson, Secretary

(314) 725-4477

kwilliamson@centene.com

If you want to receive separate copies of our proxy statements and annual reports to stockholders in the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your bank, broker or other nominee record holder, or you may contact us at the above address, phone number or e-mail address.

 

52    Centene Corporation


Table of Contents

LOGO

CENTENE CORPORATION

C/O BROADRIDGE

PO BOX 1342

BRENTWOOD, NY 11717

VOTE BY INTERNET - www.proxyvote.com

Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS

If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.

VOTE BY PHONE - 1-800-690-6903

Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions.

VOTE BY MAIL

Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

 

 

TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:   
     KEEP THIS PORTION FOR YOUR RECORDS   

— — — — — — — — — — — — —  — — — — — — — — — — — — — — — — — — — —  — — — — — — — — — —

DETACH AND RETURN THIS PORTION ONLY

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

 

  For   Withhold   For All     To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.      
  All   All   Except          
    The Board of Directors recommends you     vote FOR the following:                                                   
                    
  ¨   ¨   ¨                                                                                        

    1.     Election of Directors

               

            Nominees

               

    01    Orlando Ayala                    02    John R. Roberts                    03    Tommy G. Thompson

 

The Board of Directors recommends you vote FOR proposals 2. and 3.   For   Against   Abstain

2.

   ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.   ¨   ¨   ¨

3.

   RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.   ¨   ¨   ¨
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.      

 

Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.   
            

            

                        

Signature [PLEASE SIGN WITHIN BOX]

  Date                                             Signature (Joint Owners)   Date                                 

0000273572_1     R1.0.1.25


Table of Contents

 

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:

The Notice & Proxy Statement, Annual Review and Form 10-K are available at www.proxyvote.com

— — — — — — — — — — — — —  — — — — — — — — — — — — — — — — — — — —  — — — — — — — — — — 

 

CENTENE CORPORATION

ANNUAL MEETING OF STOCKHOLDERS, APRIL 26, 2016

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned hereby appoints Michael F. Neidorff and Keith H. Williamson and each of them, with full power of substitution, Proxies of the undersigned to vote all shares of Common Stock of Centene Corporation, standing in the name of the undersigned or with respect to which the undersigned is entitled to vote, at the Annual Meeting of Stockholders of Centene Corporation, to be held at Centene Plaza, 7700 Forsyth Blvd., St. Louis, Missouri 63105, on Tuesday, April 26, 2016, at 10:00 a.m. central daylight time, and at any adjournments thereof. If more than one of the above named Proxies shall be present in person or by substitution at such meeting or at any adjournment thereof, then both of said proxies shall exercise all of the powers hereby given. The undersigned hereby revokes any proxy heretofore given to vote at such meeting.

This proxy when properly executed will be voted in the manner directed herein by the undersigned. If no direction is made, this proxy will be voted “FOR” all the named nominees for director and “FOR” Proposals 2 and 3 and in their discretion of the named Proxies upon such other business as may properly come before the meeting and any adjournment thereof.

PLEASE MARK, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY USING THE ENCLOSED POSTAGE-PAID ENVELOPE.

 

Continued and to be signed on reverse side

0000273572_2    R1.0.1.25